BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Osafune K, Caron L, Borowiak M, Martinez RJ, Fitz-Gerald CS, Sato Y, Cowan CA, Chien KR, Melton DA. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol. 2008;26:313-315. [PMID: 18278034 DOI: 10.1038/nbt1383] [Cited by in Crossref: 622] [Cited by in F6Publishing: 532] [Article Influence: 47.8] [Reference Citation Analysis]
Number Citing Articles
1 Araoka T, Mae S, Kurose Y, Uesugi M, Ohta A, Yamanaka S, Osafune K. Efficient and rapid induction of human iPSCs/ESCs into nephrogenic intermediate mesoderm using small molecule-based differentiation methods. PLoS One. 2014;9:e84881. [PMID: 24454758 DOI: 10.1371/journal.pone.0084881] [Cited by in Crossref: 81] [Cited by in F6Publishing: 59] [Article Influence: 11.6] [Reference Citation Analysis]
2 Briggs JA, Mason EA, Ovchinnikov DA, Wells CA, Wolvetang EJ. Concise review: new paradigms for Down syndrome research using induced pluripotent stem cells: tackling complex human genetic disease. Stem Cells Transl Med 2013;2:175-84. [PMID: 23413375 DOI: 10.5966/sctm.2012-0117] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
3 Toivonen S, Ojala M, Hyysalo A, Ilmarinen T, Rajala K, Pekkanen-Mattila M, Äänismaa R, Lundin K, Palgi J, Weltner J. Comparative analysis of targeted differentiation of human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells reveals variability associated with incomplete transgene silencing in retrovirally derived hiPSC lines. Stem Cells Transl Med. 2013;2:83-93. [PMID: 23341440 DOI: 10.5966/sctm.2012-0047] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 6.5] [Reference Citation Analysis]
4 Gähwiler EKN, Motta SE, Martin M, Nugraha B, Hoerstrup SP, Emmert MY. Human iPSCs and Genome Editing Technologies for Precision Cardiovascular Tissue Engineering. Front Cell Dev Biol 2021;9:639699. [PMID: 34262897 DOI: 10.3389/fcell.2021.639699] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fang X, Miao S, Yu Y, Ding F, Han X, Wu H, Zhao Z, Wang Y, Hu S, Lei W. MIR148A family regulates cardiomyocyte differentiation of human embryonic stem cells by inhibiting the DLL1-mediated NOTCH signaling pathway. Journal of Molecular and Cellular Cardiology 2019;134:1-12. [DOI: 10.1016/j.yjmcc.2019.06.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Tapia N, Schöler HR. Molecular Obstacles to Clinical Translation of iPSCs. Cell Stem Cell 2016;19:298-309. [PMID: 27452174 DOI: 10.1016/j.stem.2016.06.017] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 16.2] [Reference Citation Analysis]
7 Dal-Pra S, Mirotsou M. Reprogramming approaches in cardiovascular regeneration. Curr Treat Options Cardiovasc Med 2014;16:327. [PMID: 24928147 DOI: 10.1007/s11936-014-0327-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
8 Skelly DA, Czechanski A, Byers C, Aydin S, Spruce C, Olivier C, Choi K, Gatti DM, Raghupathy N, Keele GR, Stanton A, Vincent M, Dion S, Greenstein I, Pankratz M, Porter DK, Martin W, O'Connor C, Qin W, Harrill AH, Choi T, Churchill GA, Munger SC, Baker CL, Reinholdt LG. Mapping the Effects of Genetic Variation on Chromatin State and Gene Expression Reveals Loci That Control Ground State Pluripotency. Cell Stem Cell 2020;27:459-469.e8. [PMID: 32795400 DOI: 10.1016/j.stem.2020.07.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
9 Ohnuki M, Takahashi K. Present and future challenges of induced pluripotent stem cells. Philos Trans R Soc Lond B Biol Sci. 2015;370:20140367. [PMID: 26416678 DOI: 10.1098/rstb.2014.0367] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 9.8] [Reference Citation Analysis]
10 Bian Q, Cahan P. Computational Tools for Stem Cell Biology. Trends Biotechnol 2016;34:993-1009. [PMID: 27318512 DOI: 10.1016/j.tibtech.2016.05.010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
11 Leschik J, Caron L, Yang H, Cowan C, Pucéat M. A view of bivalent epigenetic marks in two human embryonic stem cell lines reveals a different cardiogenic potential. Stem Cells Dev 2015;24:384-92. [PMID: 25202820 DOI: 10.1089/scd.2014.0345] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
12 Tsuyama T, Shiraki N, Kume S. Definitive Endoderm Differentiation of Human Embryonic Stem Cells Combined with Selective Elimination of Undifferentiated Cells by Methionine Deprivation. Methods Mol Biol 2016;1307:205-12. [PMID: 25822724 DOI: 10.1007/7651_2015_224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
13 Theunissen TW, Jaenisch R. Mechanisms of gene regulation in human embryos and pluripotent stem cells. Development 2017;144:4496-509. [PMID: 29254992 DOI: 10.1242/dev.157404] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 14.0] [Reference Citation Analysis]
14 Vaccarino FM, Stevens HE, Kocabas A, Palejev D, Szekely A, Grigorenko EL, Weissman S. Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders. Neuropharmacology 2011;60:1355-63. [PMID: 21371482 DOI: 10.1016/j.neuropharm.2011.02.021] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
15 Yvon C, Ramsden CM, Lane A, Powner MB, da Cruz L, Coffey PJ, Carr AJ. Using Stem Cells to Model Diseases of the Outer Retina. Comput Struct Biotechnol J 2015;13:382-9. [PMID: 26106463 DOI: 10.1016/j.csbj.2015.05.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
16 Stewart MH, Bendall SC, Levadoux-martin M, Bhatia M. Clonal tracking of hESCs reveals differential contribution to functional assays. Nat Methods 2010;7:917-22. [DOI: 10.1038/nmeth.1519] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
17 Lippmann ES, Al-Ahmad A, Palecek SP, Shusta EV. Modeling the blood-brain barrier using stem cell sources. Fluids Barriers CNS 2013;10:2. [PMID: 23305164 DOI: 10.1186/2045-8118-10-2] [Cited by in Crossref: 75] [Cited by in F6Publishing: 61] [Article Influence: 9.4] [Reference Citation Analysis]
18 Tat PA, Sumer H, Jones KL, Upton K, Verma PJ. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells. Cell Transplant 2010;19:525-36. [PMID: 20144262 DOI: 10.3727/096368910X491374] [Cited by in Crossref: 58] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
19 Telias M, Segal M, Ben-Yosef D. Neural differentiation of Fragile X human Embryonic Stem Cells reveals abnormal patterns of development despite successful neurogenesis. Dev Biol. 2013;374:32-45. [PMID: 23219959 DOI: 10.1016/j.ydbio.2012.11.031] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 8.4] [Reference Citation Analysis]
20 Jiang W, Sui X, Zhang D, Liu M, Ding M, Shi Y, Deng H. CD24: A Novel Surface Marker for PDX1-Positive Pancreatic Progenitors Derived from Human Embryonic Stem Cells. STEM CELLS 2011;29:609-17. [DOI: 10.1002/stem.608] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 5.2] [Reference Citation Analysis]
21 Wright A, Andrews N, Bardsley K, Nielsen JE, Avery K, Pewsey E, Jones M, Harley D, Nielsen AR, Moore H. Mapping the stem cell state: eight novel human embryonic stem and embryonal carcinoma cell antibodies. Int J Androl. 2011;34:e175-e187; discussion e175-e187. [PMID: 21651578 DOI: 10.1111/j.1365-2605.2011.01185.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
22 Patterson M, Chan DN, Ha I, Case D, Cui Y, Van Handel B, Mikkola HK, Lowry WE. Defining the nature of human pluripotent stem cell progeny. Cell Res. 2012;22:178-193. [PMID: 21844894 DOI: 10.1038/cr.2011.133] [Cited by in Crossref: 98] [Cited by in F6Publishing: 81] [Article Influence: 9.8] [Reference Citation Analysis]
23 Tanaka A, Woltjen K, Miyake K, Hotta A, Ikeya M, Yamamoto T, Nishino T, Shoji E, Sehara-Fujisawa A, Manabe Y, Fujii N, Hanaoka K, Era T, Yamashita S, Isobe K, Kimura E, Sakurai H. Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro. PLoS One. 2013;8:e61540. [PMID: 23626698 DOI: 10.1371/journal.pone.0061540] [Cited by in Crossref: 118] [Cited by in F6Publishing: 119] [Article Influence: 14.8] [Reference Citation Analysis]
24 Inoue Y, Hasegawa S, Yamada T, Date Y, Mizutani H, Nakata S, Matsunaga K, Akamatsu H. Bimodal effect of retinoic acid on melanocyte differentiation identified by time-dependent analysis: Bimodal effect of retinoic acid. Pigment Cell & Melanoma Research 2012;25:299-311. [DOI: 10.1111/j.1755-148x.2012.00988.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
25 Brennand KJ, Simone A, Tran N, Gage FH. Modeling psychiatric disorders at the cellular and network levels. Mol Psychiatry 2012;17:1239-53. [PMID: 22472874 DOI: 10.1038/mp.2012.20] [Cited by in Crossref: 85] [Cited by in F6Publishing: 74] [Article Influence: 9.4] [Reference Citation Analysis]
26 Nehlin JO, Barington T. Strategies for future histocompatible stem cell therapy. Biogerontology 2009;10:339-76. [PMID: 19219637 DOI: 10.1007/s10522-009-9213-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
27 Morizane R, Bonventre JV. Generation of nephron progenitor cells and kidney organoids from human pluripotent stem cells. Nat Protoc 2017;12:195-207. [PMID: 28005067 DOI: 10.1038/nprot.2016.170] [Cited by in Crossref: 83] [Cited by in F6Publishing: 64] [Article Influence: 16.6] [Reference Citation Analysis]
28 Juopperi TA, Song H, Ming GL. Modeling neurological diseases using patient-derived induced pluripotent stem cells. Future Neurol 2011;6:363-73. [PMID: 21731471 DOI: 10.2217/FNL.11.14] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
29 Kim SI, Matsumoto T, Kagawa H, Nakamura M, Hirohata R, Ueno A, Ohishi M, Sakuma T, Soga T, Yamamoto T, Woltjen K. Microhomology-assisted scarless genome editing in human iPSCs. Nat Commun 2018;9:939. [PMID: 29507284 DOI: 10.1038/s41467-018-03044-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 11.7] [Reference Citation Analysis]
30 Balafkan N, Mostafavi S, Schubert M, Siller R, Liang KX, Sullivan G, Bindoff LA. A method for differentiating human induced pluripotent stem cells toward functional cardiomyocytes in 96-well microplates. Sci Rep 2020;10:18498. [PMID: 33116175 DOI: 10.1038/s41598-020-73656-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
31 Siehler J, Blöchinger AK, Meier M, Lickert H. Engineering islets from stem cells for advanced therapies of diabetes. Nat Rev Drug Discov 2021. [PMID: 34376833 DOI: 10.1038/s41573-021-00262-w] [Reference Citation Analysis]
32 Chang DJ, Lee N, Park IH, Choi C, Jeon I, Kwon J, Oh SH, Shin DA, Do JT, Lee DR, Lee H, Moon H, Hong KS, Daley GQ, Song J. Therapeutic potential of human induced pluripotent stem cells in experimental stroke. Cell Transplant 2013;22:1427-40. [PMID: 23044029 DOI: 10.3727/096368912X657314] [Cited by in Crossref: 51] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
33 Djuric U, Ellis J. Epigenetics of induced pluripotency, the seven-headed dragon. Stem Cell Res Ther 2010;1:3. [PMID: 20504284 DOI: 10.1186/scrt3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
34 Fatima A, Xu G, Shao K, Papadopoulos S, Lehmann M, Arnáiz-Cot JJ, Rosa AO, Nguemo F, Matzkies M, Dittmann S. In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells. Cell Physiol Biochem. 2011;28:579-592. [PMID: 22178870 DOI: 10.1159/000335753] [Cited by in Crossref: 140] [Cited by in F6Publishing: 120] [Article Influence: 14.0] [Reference Citation Analysis]
35 Mandal A, Bhowmik S, Patki A, Viswanathan C, Majumdar AS. Derivation, characterization, and gene expression profile of two new human ES cell lines from India. Stem Cell Res 2010;5:173-87. [PMID: 20826120 DOI: 10.1016/j.scr.2010.07.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
36 Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LI, Yabuuchi A, Takeuchi A, Cunniff KC, Hongguang H, McKinney-Freeman S, Naveiras O, Yoon TJ, Irizarry RA, Jung N, Seita J, Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin SH, Weissman IL, Feinberg AP, Daley GQ. Epigenetic memory in induced pluripotent stem cells. Nature. 2010;467:285-290. [PMID: 20644535 DOI: 10.1038/nature09342] [Cited by in Crossref: 1551] [Cited by in F6Publishing: 1324] [Article Influence: 141.0] [Reference Citation Analysis]
37 Jiang W, Wang J, Zhang Y. Histone H3K27me3 demethylases KDM6A and KDM6B modulate definitive endoderm differentiation from human ESCs by regulating WNT signaling pathway. Cell Res 2013;23:122-30. [PMID: 22907667 DOI: 10.1038/cr.2012.119] [Cited by in Crossref: 90] [Cited by in F6Publishing: 79] [Article Influence: 10.0] [Reference Citation Analysis]
38 Chen PY, Feng S, Joo JW, Jacobsen SE, Pellegrini M. A comparative analysis of DNA methylation across human embryonic stem cell lines. Genome Biol 2011;12:R62. [PMID: 21733148 DOI: 10.1186/gb-2011-12-7-r62] [Cited by in Crossref: 73] [Cited by in F6Publishing: 64] [Article Influence: 7.3] [Reference Citation Analysis]
39 Wang YC, Lin V, Loring JF, Peterson SE. The 'sweet' spot of cellular pluripotency: protein glycosylation in human pluripotent stem cells and its applications in regenerative medicine. Expert Opin Biol Ther 2015;15:679-87. [PMID: 25736263 DOI: 10.1517/14712598.2015.1021329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
40 He P, Fu J, Wang DA. Murine pluripotent stem cells derived scaffold-free cartilage grafts from a micro-cavitary hydrogel platform. Acta Biomater 2016;35:87-97. [PMID: 26911880 DOI: 10.1016/j.actbio.2016.02.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
41 Diekmann U, Lenzen S, Naujok O. A Reliable and Efficient Protocol for Human Pluripotent Stem Cell Differentiation into the Definitive Endoderm Based on Dispersed Single Cells. Stem Cells and Development 2015;24:190-204. [DOI: 10.1089/scd.2014.0143] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
42 Menasché P, Vanneaux V, Fabreguettes JR, Bel A, Tosca L, Garcia S, Bellamy V, Farouz Y, Pouly J, Damour O, Périer MC, Desnos M, Hagège A, Agbulut O, Bruneval P, Tachdjian G, Trouvin JH, Larghero J. Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience. Eur Heart J 2015;36:743-50. [PMID: 24835485 DOI: 10.1093/eurheartj/ehu192] [Cited by in Crossref: 111] [Cited by in F6Publishing: 95] [Article Influence: 15.9] [Reference Citation Analysis]
43 Han JW, Yoon YS. Induced pluripotent stem cells: emerging techniques for nuclear reprogramming. Antioxid Redox Signal 2011;15:1799-820. [PMID: 21194386 DOI: 10.1089/ars.2010.3814] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
44 Furth ME, Atala A. Stem cell sources to treat diabetes. J Cell Biochem 2009;106:507-11. [PMID: 19130494 DOI: 10.1002/jcb.22000] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
45 Tateno H, Matsushima A, Hiemori K, Onuma Y, Ito Y, Hasehira K, Nishimura K, Ohtaka M, Takayasu S, Nakanishi M, Ikehara Y, Nakanishi M, Ohnuma K, Chan T, Toyoda M, Akutsu H, Umezawa A, Asashima M, Hirabayashi J. Podocalyxin is a glycoprotein ligand of the human pluripotent stem cell-specific probe rBC2LCN. Stem Cells Transl Med 2013;2:265-73. [PMID: 23526252 DOI: 10.5966/sctm.2012-0154] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 6.8] [Reference Citation Analysis]
46 Féraud O, Valogne Y, Melkus MW, Zhang Y, Oudrhiri N, Haddad R, Daury A, Rocher C, Larbi A, Duquesnoy P, Divers D, Gobbo E, Brunet de la Grange P, Louache F, Bennaceur-Griscelli A, Mitjavila-Garcia MT. Donor Dependent Variations in Hematopoietic Differentiation among Embryonic and Induced Pluripotent Stem Cell Lines. PLoS One 2016;11:e0149291. [PMID: 26938212 DOI: 10.1371/journal.pone.0149291] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
47 Huang SX, Green MD, de Carvalho AT, Mumau M, Chen YW, D'Souza SL, Snoeck HW. The in vitro generation of lung and airway progenitor cells from human pluripotent stem cells. Nat Protoc 2015;10:413-25. [PMID: 25654758 DOI: 10.1038/nprot.2015.023] [Cited by in Crossref: 102] [Cited by in F6Publishing: 87] [Article Influence: 17.0] [Reference Citation Analysis]
48 Cahan P, Daley GQ. Origins and implications of pluripotent stem cell variability and heterogeneity. Nat Rev Mol Cell Biol. 2013;14:357-368. [PMID: 23673969 DOI: 10.1038/nrm3584] [Cited by in Crossref: 215] [Cited by in F6Publishing: 171] [Article Influence: 26.9] [Reference Citation Analysis]
49 Kovacic B, Rosner M, Schlangen K, Kramer N, Hengstschläger M. DRUGPATH - a novel bioinformatic approach identifies DNA-damage pathway as a regulator of size maintenance in human ESCs and iPSCs. Sci Rep 2019;9:1897. [PMID: 30760778 DOI: 10.1038/s41598-018-37491-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Morizane R, Lam AQ, Freedman BS, Kishi S, Valerius MT, Bonventre JV. Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat Biotechnol. 2015;33:1193-1200. [PMID: 26458176 DOI: 10.1038/nbt.3392] [Cited by in Crossref: 394] [Cited by in F6Publishing: 312] [Article Influence: 78.8] [Reference Citation Analysis]
51 Sugawara T, Nishino K, Umezawa A, Akutsu H. Investigating cellular identity and manipulating cell fate using induced pluripotent stem cells. Stem Cell Res Ther 2012;3:8. [PMID: 22405125 DOI: 10.1186/scrt99] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
52 Földes G, Harding SE, Ali NN. Cardiomyocytes from embryonic stem cells: towards human therapy. Expert Opinion on Biological Therapy 2008;8:1473-83. [DOI: 10.1517/14712598.8.10.1473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
53 Hitomi H, Kasahara T, Katagiri N, Hoshina A, Mae S, Kotaka M, Toyohara T, Rahman A, Nakano D, Niwa A, Saito MK, Nakahata T, Nishiyama A, Osafune K. Human pluripotent stem cell–derived erythropoietin-producing cells ameliorate renal anemia in mice. Sci Transl Med 2017;9:eaaj2300. [DOI: 10.1126/scitranslmed.aaj2300] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
54 Dziedzicka D, Tewary M, Keller A, Tilleman L, Prochazka L, Östblom J, Couvreu De Deckersberg E, Markouli C, Franck S, Van Nieuwerburgh F, Spits C, Zandstra PW, Sermon K, Geens M. Endogenous suppression of WNT signalling in human embryonic stem cells leads to low differentiation propensity towards definitive endoderm. Sci Rep 2021;11:6137. [PMID: 33731744 DOI: 10.1038/s41598-021-85447-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
55 Thakur G, Lee HJ, Jeon RH, Lee SL, Rho GJ. Small Molecule-Induced Pancreatic β-Like Cell Development: Mechanistic Approaches and Available Strategies. Int J Mol Sci 2020;21:E2388. [PMID: 32235681 DOI: 10.3390/ijms21072388] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
56 Kitazawa A, Shimizu N. Differentiation of mouse induced pluripotent stem cells into neurons using conditioned medium of dorsal root ganglia. New Biotechnology 2011;28:326-33. [DOI: 10.1016/j.nbt.2011.03.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
57 Chetty S, Engquist EN, Mehanna E, Lui KO, Tsankov AM, Melton DA. A Src inhibitor regulates the cell cycle of human pluripotent stem cells and improves directed differentiation. J Cell Biol 2015;210:1257-68. [PMID: 26416968 DOI: 10.1083/jcb.201502035] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
58 Borowiak M, Melton DA. How to make beta cells? Curr Opin Cell Biol. 2009;21:727-732. [PMID: 19781928 DOI: 10.1016/j.ceb.2009.08.006] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
59 Myszczynska M, Ferraiuolo L. New In Vitro Models to Study Amyotrophic Lateral Sclerosis. Brain Pathol 2016;26:258-65. [PMID: 26780562 DOI: 10.1111/bpa.12353] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
60 Wu J, Izpisua Belmonte JC. Dynamic Pluripotent Stem Cell States and Their Applications. Cell Stem Cell 2015;17:509-25. [PMID: 26544113 DOI: 10.1016/j.stem.2015.10.009] [Cited by in Crossref: 106] [Cited by in F6Publishing: 88] [Article Influence: 21.2] [Reference Citation Analysis]
61 Vaccarino FM, Urban AE, Stevens HE, Szekely A, Abyzov A, Grigorenko EL, Gerstein M, Weissman S. Annual Research Review: The promise of stem cell research for neuropsychiatric disorders. J Child Psychol Psychiatry 2011;52:504-16. [PMID: 21204834 DOI: 10.1111/j.1469-7610.2010.02348.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
62 Tanaka A, Yuasa S, Node K, Fukuda K. Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells. Int J Mol Sci 2015;16:18894-922. [PMID: 26274955 DOI: 10.3390/ijms160818894] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
63 Chetty S, Pagliuca FW, Honore C, Kweudjeu A, Rezania A, Melton DA. A simple tool to improve pluripotent stem cell differentiation. Nat Methods. 2013;10:553-556. [PMID: 23584186 DOI: 10.1038/nmeth.2442] [Cited by in Crossref: 122] [Cited by in F6Publishing: 106] [Article Influence: 15.3] [Reference Citation Analysis]
64 Avery K, Avery S, Shepherd J, Heath PR, Moore H. Sphingosine-1-phosphate mediates transcriptional regulation of key targets associated with survival, proliferation, and pluripotency in human embryonic stem cells. Stem Cells Dev. 2008;17:1195-1205. [PMID: 18393631 DOI: 10.1089/scd.2008.0063] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 4.4] [Reference Citation Analysis]
65 Sun B, Yu W, Wang F, Song W, Jin H, Sun Y. Effects of group culture on the development of discarded human embryos and the construction of human embryonic stem cell lines. J Assist Reprod Genet 2014;31:1369-76. [PMID: 25113620 DOI: 10.1007/s10815-014-0308-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
66 Sun C, Zhang J, Zheng D, Wang J, Yang H, Zhang X. Transcriptome variations among human embryonic stem cell lines are associated with their differentiation propensity. PLoS One. 2018;13:e0192625. [PMID: 29444173 DOI: 10.1371/journal.pone.0192625] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
67 Sonntag KC, Song B, Lee N, Jung JH, Cha Y, Leblanc P, Neff C, Kong SW, Carter BS, Schweitzer J, Kim KS. Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects. Prog Neurobiol. 2018;168:1-20. [PMID: 29653250 DOI: 10.1016/j.pneurobio.2018.04.005] [Cited by in Crossref: 39] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
68 Harkness L, Chen X, Gillard M, Gray PP, Davies AM. Media composition modulates human embryonic stem cell morphology and may influence preferential lineage differentiation potential. PLoS One 2019;14:e0213678. [PMID: 30889226 DOI: 10.1371/journal.pone.0213678] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
69 Huang SX, Islam MN, O'Neill J, Hu Z, Yang YG, Chen YW, Mumau M, Green MD, Vunjak-Novakovic G, Bhattacharya J, Snoeck HW. Efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat Biotechnol. 2014;32:84-91. [PMID: 24291815 DOI: 10.1038/nbt.2754] [Cited by in Crossref: 335] [Cited by in F6Publishing: 279] [Article Influence: 41.9] [Reference Citation Analysis]
70 Haellman V, Saxena P, Jiang Y, Fussenegger M. Rational design and optimization of synthetic gene switches for controlling cell-fate decisions in pluripotent stem cells. Metab Eng 2021;65:99-110. [PMID: 33744461 DOI: 10.1016/j.ymben.2021.03.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
71 Liu LP, Zheng YW. Predicting differentiation potential of human pluripotent stem cells: Possibilities and challenges. World J Stem Cells. 2019;11:375-382. [PMID: 31396366 DOI: 10.4252/wjsc.v11.i7.375] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
72 Vieira MS, Santos AK, Vasconcellos R, Goulart VAM, Parreira RC, Kihara AH, Ulrich H, Resende RR. Neural stem cell differentiation into mature neurons: Mechanisms of regulation and biotechnological applications. Biotechnol Adv 2018;36:1946-70. [PMID: 30077716 DOI: 10.1016/j.biotechadv.2018.08.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 11.3] [Reference Citation Analysis]
73 Ahmad R, Sportelli V, Ziller M, Spengler D, Hoffmann A. Tracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem Cells. Cells 2018;7:E140. [PMID: 30227641 DOI: 10.3390/cells7090140] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
74 Carpenter MK, Frey-Vasconcells J, Rao MS. Developing safe therapies from human pluripotent stem cells. Nat Biotechnol 2009;27:606-13. [PMID: 19587662 DOI: 10.1038/nbt0709-606] [Cited by in Crossref: 103] [Cited by in F6Publishing: 82] [Article Influence: 8.6] [Reference Citation Analysis]
75 Kisa F, Shiozawa S, Oda K, Yoshimatsu S, Nakamura M, Koya I, Kawai K, Suzuki S, Okano H. Naive-like ESRRB+ iPSCs with the Capacity for Rapid Neural Differentiation. Stem Cell Reports 2017;9:1825-38. [PMID: 29129686 DOI: 10.1016/j.stemcr.2017.10.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
76 Zhang Y, Pak C, Han Y, Ahlenius H, Zhang Z, Chanda S, Marro S, Patzke C, Acuna C, Covy J. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron. 2013;78:785-798. [PMID: 23764284 DOI: 10.1016/j.neuron.2013.05.029] [Cited by in Crossref: 657] [Cited by in F6Publishing: 543] [Article Influence: 82.1] [Reference Citation Analysis]
77 Sulzbacher S, Schroeder IS, Truong TT, Wobus AM. Activin A-Induced Differentiation of Embryonic Stem Cells into Endoderm and Pancreatic Progenitors—The Influence of Differentiation Factors and Culture Conditions. Stem Cell Rev and Rep 2009;5:159-73. [DOI: 10.1007/s12015-009-9061-5] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
78 Kim KY, Hysolli E, Park IH. Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. Proc Natl Acad Sci USA. 2011;108:14169-14174. [PMID: 21807996 DOI: 10.1073/pnas.1018979108] [Cited by in Crossref: 148] [Cited by in F6Publishing: 138] [Article Influence: 14.8] [Reference Citation Analysis]
79 Duggal G, Heindryckx B, Warrier S, O'Leary T, Van der Jeught M, Lierman S, Vossaert L, Deroo T, Deforce D, Chuva de Sousa Lopes SM, De Sutter P. Influence of activin A supplementation during human embryonic stem cell derivation on germ cell differentiation potential. Stem Cells Dev 2013;22:3141-55. [PMID: 23829223 DOI: 10.1089/scd.2013.0024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
80 Zhu L, Gomez-Duran A, Saretzki G, Jin S, Tilgner K, Melguizo-Sanchis D, Anyfantis G, Al-Aama J, Vallier L, Chinnery P, Lako M, Armstrong L. The mitochondrial protein CHCHD2 primes the differentiation potential of human induced pluripotent stem cells to neuroectodermal lineages. J Cell Biol 2016;215:187-202. [PMID: 27810911 DOI: 10.1083/jcb.201601061] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
81 Young DA, DeQuach JA, Christman KL. Human cardiomyogenesis and the need for systems biology analysis. Wiley Interdiscip Rev Syst Biol Med 2011;3:666-80. [PMID: 21197666 DOI: 10.1002/wsbm.141] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
82 Fowler JL, Ang LT, Loh KM. A critical look: Challenges in differentiating human pluripotent stem cells into desired cell types and organoids. Wiley Interdiscip Rev Dev Biol 2020;9:e368. [PMID: 31746148 DOI: 10.1002/wdev.368] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
83 Mfopou JK, Chen B, Mateizel I, Sermon K, Bouwens L. Noggin, Retinoids, and Fibroblast Growth Factor Regulate Hepatic or Pancreatic Fate of Human Embryonic Stem Cells. Gastroenterology 2010;138:2233-2245.e14. [DOI: 10.1053/j.gastro.2010.02.056] [Cited by in Crossref: 115] [Cited by in F6Publishing: 104] [Article Influence: 10.5] [Reference Citation Analysis]
84 Chang KH, Nelson AM, Fields PA, Hesson JL, Ulyanova T, Cao H, Nakamoto B, Ware CB, Papayannopoulou T. Diverse hematopoietic potentials of five human embryonic stem cell lines. Exp Cell Res. 2008;314:2930-2940. [PMID: 18692044 DOI: 10.1016/j.yexcr.2008.07.019] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
85 Kuboth S, Kramer J, Rohwedel J. Chondrogenic differentiation in vitro of murine two-factor induced pluripotent stem cells is comparable to murine embryonic stem cells. Cells Tissues Organs 2012;196:481-9. [PMID: 22797361 DOI: 10.1159/000338527] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
86 Toyoda M, Yamazaki-Inoue M, Itakura Y, Kuno A, Ogawa T, Yamada M, Akutsu H, Takahashi Y, Kanzaki S, Narimatsu H, Hirabayashi J, Umezawa A. Lectin microarray analysis of pluripotent and multipotent stem cells. Genes Cells 2011;16:1-11. [PMID: 21155951 DOI: 10.1111/j.1365-2443.2010.01459.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 53] [Article Influence: 6.2] [Reference Citation Analysis]
87 Li Y, Wen Y, Green M, Cabral EK, Wani P, Zhang F, Wei Y, Baer TM, Chen B. Cell sex affects extracellular matrix protein expression and proliferation of smooth muscle progenitor cells derived from human pluripotent stem cells. Stem Cell Res Ther 2017;8:156. [PMID: 28676082 DOI: 10.1186/s13287-017-0606-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
88 Kramer AS, Harvey AR, Plant GW, Hodgetts SI. Systematic Review of Induced Pluripotent Stem Cell Technology as a Potential Clinical Therapy for Spinal Cord Injury. Cell Transplant 2013;22:571-617. [DOI: 10.3727/096368912x655208] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
89 Onuma Y, Higuchi K, Aiki Y, Shu Y, Asada M, Asashima M, Suzuki M, Imamura T, Ito Y. A stable chimeric fibroblast growth factor (FGF) can successfully replace basic FGF in human pluripotent stem cell culture. PLoS One 2015;10:e0118931. [PMID: 25850016 DOI: 10.1371/journal.pone.0118931] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
90 Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S, Muhlestein W, Melton DA. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol. 2008;26:1269-1275. [PMID: 18849973 DOI: 10.1038/nbt.1502] [Cited by in Crossref: 943] [Cited by in F6Publishing: 807] [Article Influence: 72.5] [Reference Citation Analysis]
91 Nagvenkar P, Pethe P, Pawani H, Telang J, Kumar N, Hinduja I, Zaveri K, Bhartiya D. Evaluating differentiation propensity of in-house derived human embryonic stem cell lines KIND-1 and KIND-2. In Vitro Cell Dev Biol Anim 2011;47:406-19. [PMID: 21614653 DOI: 10.1007/s11626-011-9420-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
92 Drummond NJ, Singh Dolt K, Canham MA, Kilbride P, Morris GJ, Kunath T. Cryopreservation of Human Midbrain Dopaminergic Neural Progenitor Cells Poised for Neuronal Differentiation. Front Cell Dev Biol 2020;8:578907. [PMID: 33224948 DOI: 10.3389/fcell.2020.578907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
93 Pournasr B, Duncan SA. Modeling Inborn Errors of Hepatic Metabolism Using Induced Pluripotent Stem Cells. Arterioscler Thromb Vasc Biol 2017;37:1994-9. [PMID: 28818857 DOI: 10.1161/ATVBAHA.117.309199] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
94 Seah YF, El Farran CA, Warrier T, Xu J, Loh YH. Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges. Int J Mol Sci 2015;16:28614-34. [PMID: 26633382 DOI: 10.3390/ijms161226119] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
95 O'leary T, Heindryckx B, Lierman S, Van der Jeught M, Duggal G, De Sutter P, Chuva de Sousa Lopes SM. Derivation of human embryonic stem cells using a post–inner cell mass intermediate. Nat Protoc 2013;8:254-64. [DOI: 10.1038/nprot.2012.157] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
96 Kumar N, Hinduja I, Nagvenkar P, Pillai L, Zaveri K, Mukadam L, Telang J, Desai S, Mangoli V, Mangoli R, Padgaonkar S, Kaur G, Puri C, Bhartiya D. Derivation and Characterization of Two Genetically Unique Human Embryonic Stem Cell Lines on In-House–Derived Human Feeders. Stem Cells and Development 2009;18:435-46. [DOI: 10.1089/scd.2008.0234] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
97 Loh YH, Yang L, Yang JC, Li H, Collins JJ, Daley GQ. Genomic approaches to deconstruct pluripotency. Annu Rev Genomics Hum Genet 2011;12:165-85. [PMID: 21801025 DOI: 10.1146/annurev-genom-082410-101506] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
98 Song B, Sun G, Herszfeld D, Sylvain A, Campanale NV, Hirst CE, Caine S, Parkington HC, Tonta MA, Coleman HA. Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis. Stem Cell Res. 2012;8:259-273. [PMID: 22265745 DOI: 10.1016/j.scr.2011.12.001] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 6.5] [Reference Citation Analysis]
99 Phillips BW, Crook JM. Pluripotent Human Stem Cells: A Novel Tool in Drug Discovery. BioDrugs 2010;24:99-108. [DOI: 10.2165/11532270-000000000-00000] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
100 Spitalieri P, Talarico RV, Botta A, Murdocca M, D’Apice MR, Orlandi A, Giardina E, Santoro M, Brancati F, Novelli G. Generation of Human Induced Pluripotent Stem Cells from Extraembryonic Tissues of Fetuses Affected by Monogenic Diseases. Cell Reprogram. 2015;17:275-287. [PMID: 26474030 DOI: 10.1089/cell.2015.0003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
101 Phanthong P, Raveh-Amit H, Li T, Kitiyanant Y, Dinnyes A. Is aging a barrier to reprogramming? Lessons from induced pluripotent stem cells. Biogerontology 2013;14:591-602. [PMID: 23963527 DOI: 10.1007/s10522-013-9455-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
102 Lee H, Park J, Forget BG, Gaines P. Induced pluripotent stem cells in regenerative medicine: an argument for continued research on human embryonic stem cells. Regenerative Medicine 2009;4:759-69. [DOI: 10.2217/rme.09.46] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
103 Yusa K. Seamless genome editing in human pluripotent stem cells using custom endonuclease-based gene targeting and the piggyBac transposon. Nat Protoc. 2013;8:2061-2078. [PMID: 24071911 DOI: 10.1038/nprot.2013.126] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 7.0] [Reference Citation Analysis]
104 Lefort N, Perrier AL, Laâbi Y, Varela C, Peschanski M. Human embryonic stem cells and genomic instability. Regen Med 2009;4:899-909. [PMID: 19903007 DOI: 10.2217/rme.09.63] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
105 Yedid N, Kalma Y, Malcov M, Amit A, Kariv R, Caspi M, Rosin-Arbesfeld R, Ben-Yosef D. The effect of a germline mutation in the APC gene on β-catenin in human embryonic stem cells. BMC Cancer 2016;16:952. [PMID: 28010732 DOI: 10.1186/s12885-016-2809-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
106 Bosman A, Letourneau A, Sartiani L, Del Lungo M, Ronzoni F, Kuziakiv R, Tohonen V, Zucchelli M, Santoni F, Guipponi M, Dumevska B, Hovatta O, Antonarakis SE, Jaconi ME. Perturbations of Heart Development and Function in Cardiomyocytes from Human Embryonic Stem Cells with Trisomy 21: Perturbed Cardiogenesis in hESC with Trisomy 21. Stem Cells 2015;33:1434-46. [DOI: 10.1002/stem.1961] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
107 Kaufman DS. Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells. Blood. 2009;114:3513-3523. [PMID: 19652198 DOI: 10.1182/blood-2009-03-191304] [Cited by in Crossref: 114] [Cited by in F6Publishing: 100] [Article Influence: 9.5] [Reference Citation Analysis]
108 Aoi T. 10th anniversary of iPS cells: the challenges that lie ahead. J Biochem. 2016;160:121-129. [PMID: 27387749 DOI: 10.1093/jb/mvw044] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
109 Haidet-Phillips AM, Roybon L, Gross SK, Tuteja A, Donnelly CJ, Richard JP, Ko M, Sherman A, Eggan K, Henderson CE. Gene profiling of human induced pluripotent stem cell-derived astrocyte progenitors following spinal cord engraftment. Stem Cells Transl Med. 2014;3:575-585. [PMID: 24604284 DOI: 10.5966/sctm.2013-0153] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
110 Xie AW, Binder BYK, Khalil AS, Schmitt SK, Johnson HJ, Zacharias NA, Murphy WL. Controlled Self-assembly of Stem Cell Aggregates Instructs Pluripotency and Lineage Bias. Sci Rep 2017;7:14070. [PMID: 29070799 DOI: 10.1038/s41598-017-14325-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
111 Yamauchi K, Sumi T, Minami I, Otsuji TG, Kawase E, Nakatsuji N, Suemori H. Cardiomyocytes develop from anterior primitive streak cells induced by β-catenin activation and the blockage of BMP signaling in hESCs. Genes Cells 2010;15:1216-27. [PMID: 21050342 DOI: 10.1111/j.1365-2443.2010.01455.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
112 Yoshida Y, Yamanaka S. Recent Stem Cell Advances: Induced Pluripotent Stem Cells for Disease Modeling and Stem Cell–Based Regeneration. Circulation 2010;122:80-7. [DOI: 10.1161/circulationaha.109.881433] [Cited by in Crossref: 124] [Cited by in F6Publishing: 66] [Article Influence: 11.3] [Reference Citation Analysis]
113 Vallier L. Putting induced pluripotent stem cells to the test. Nat Biotechnol 2015;33:1145-6. [DOI: 10.1038/nbt.3401] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
114 Muratore CR, Srikanth P, Callahan DG, Young-Pearse TL. Comparison and optimization of hiPSC forebrain cortical differentiation protocols. PLoS One. 2014;9:e105807. [PMID: 25165848 DOI: 10.1371/journal.pone.0105807] [Cited by in Crossref: 63] [Cited by in F6Publishing: 49] [Article Influence: 9.0] [Reference Citation Analysis]
115 Baxter MA, Rowe C, Alder J, Harrison S, Hanley KP, Park BK, Kitteringham NR, Goldring CE, Hanley NA. Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening. Stem Cell Res 2010;5:4-22. [PMID: 20483202 DOI: 10.1016/j.scr.2010.02.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
116 Hicks MR, Hiserodt J, Paras K, Fujiwara W, Eskin A, Jan M, Xi H, Young CS, Evseenko D, Nelson SF, Spencer MJ, Handel BV, Pyle AD. ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs. Nat Cell Biol 2018;20:46-57. [PMID: 29255171 DOI: 10.1038/s41556-017-0010-2] [Cited by in Crossref: 79] [Cited by in F6Publishing: 57] [Article Influence: 19.8] [Reference Citation Analysis]
117 Oldershaw RA, Baxter MA, Lowe ET, Bates N, Grady LM, Soncin F, Brison DR, Hardingham TE, Kimber SJ. Directed differentiation of human embryonic stem cells toward chondrocytes. Nat Biotechnol. 2010;28:1187-1194. [PMID: 20967028 DOI: 10.1038/nbt.1683] [Cited by in Crossref: 201] [Cited by in F6Publishing: 158] [Article Influence: 18.3] [Reference Citation Analysis]
118 Teramura T, Frampton J. Induced pluripotent stem cells in reproductive medicine. Reprod Med Biol 2013;12:39-46. [PMID: 29699129 DOI: 10.1007/s12522-012-0141-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
119 Wang YC, Peterson SE, Loring JF. Protein post-translational modifications and regulation of pluripotency in human stem cells. Cell Res 2014;24:143-60. [PMID: 24217768 DOI: 10.1038/cr.2013.151] [Cited by in Crossref: 174] [Cited by in F6Publishing: 134] [Article Influence: 21.8] [Reference Citation Analysis]
120 Philonenko ES, Shutova MV, Chestkov IV, Lagarkova MA, Kiselev SL. Current progress and potential practical application for human pluripotent stem cells. Int Rev Cell Mol Biol. 2011;292:153-196. [PMID: 22078961 DOI: 10.1016/b978-0-12-386033-0.00004-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
121 Mason C, Dunnill P. Assessing the value of autologous and allogeneic cells for regenerative medicine. Regen Med 2009;4:835-53. [PMID: 19903003 DOI: 10.2217/rme.09.64] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
122 Bradley CK, Scott HA, Chami O, Peura TT, Dumevska B, Schmidt U, Stojanov T. Derivation of Huntington's Disease-Affected Human Embryonic Stem Cell Lines. Stem Cells and Development 2011;20:495-502. [DOI: 10.1089/scd.2010.0120] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 5.5] [Reference Citation Analysis]
123 Nishihara K, Shiga T, Nakamura E, Akiyama T, Sasaki T, Suzuki S, Ko MSH, Tada N, Okano H, Akamatsu W. Induced Pluripotent Stem Cells Reprogrammed with Three Inhibitors Show Accelerated Differentiation Potentials with High Levels of 2-Cell Stage Marker Expression. Stem Cell Reports. 2019;12:305-318. [PMID: 30713040 DOI: 10.1016/j.stemcr.2018.12.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
124 Zimmerlin L, Park TS, Zambidis ET. Capturing Human Naïve Pluripotency in the Embryo and in the Dish. Stem Cells Dev 2017;26:1141-61. [PMID: 28537488 DOI: 10.1089/scd.2017.0055] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
125 Närvä E, Autio R, Rahkonen N, Kong L, Harrison N, Kitsberg D, Borghese L, Itskovitz-Eldor J, Rasool O, Dvorak P. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol. 2010;28:371-377. [PMID: 20351689 DOI: 10.1038/nbt.1615] [Cited by in Crossref: 196] [Cited by in F6Publishing: 178] [Article Influence: 17.8] [Reference Citation Analysis]
126 Naujok O, Burns C, Jones PM, Lenzen S. Insulin-producing surrogate β-cells from embryonic stem cells: are we there yet? Mol Ther. 2011;19:1759-1768. [PMID: 21829172 DOI: 10.1038/mt.2011.165] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
127 Bohaciakova D, Hruska-Plochan M, Tsunemoto R, Gifford WD, Driscoll SP, Glenn TD, Wu S, Marsala S, Navarro M, Tadokoro T, Juhas S, Juhasova J, Platoshyn O, Piper D, Sheckler V, Ditsworth D, Pfaff SL, Marsala M. A scalable solution for isolating human multipotent clinical-grade neural stem cells from ES precursors. Stem Cell Res Ther 2019;10:83. [PMID: 30867054 DOI: 10.1186/s13287-019-1163-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
128 Stocum DL, Zupanc GK. Stretching the limits: Stem cells in regeneration science. Dev Dyn 2008;237:3648-71. [DOI: 10.1002/dvdy.21774] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
129 Carpenter MK, Couture LA. Regulatory considerations for the development of autologous induced pluripotent stem cell therapies. Regenerative Medicine 2010;5:569-79. [DOI: 10.2217/rme.10.55] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
130 Latham KE, Sapienza C, Engel N. The epigenetic lorax: gene-environment interactions in human health. Epigenomics. 2012;4:383-402. [PMID: 22920179 DOI: 10.2217/epi.12.31] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
131 Loo LSW, Lau HH, Jasmen JB, Lim CS, Teo AKK. An arduous journey from human pluripotent stem cells to functional pancreatic β cells. Diabetes Obes Metab 2018;20:3-13. [PMID: 28474496 DOI: 10.1111/dom.12996] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
132 Mamo S, Kobolak J, Borbíró I, Bíró T, Bock I, Dinnyes A. Gene targeting and Calcium handling efficiencies in mouse embryonic stem cell lines. World J Stem Cells 2010;2:127-40. [PMID: 21607130 DOI: 10.4252/wjsc.v2.i6.127] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
133 Martins AM, Vunjak-Novakovic G, Reis RL. The current status of iPS cells in cardiac research and their potential for tissue engineering and regenerative medicine. Stem Cell Rev Rep 2014;10:177-90. [PMID: 24425421 DOI: 10.1007/s12015-013-9487-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 25] [Article Influence: 5.9] [Reference Citation Analysis]
134 Watarai H, Fujii S, Yamada D, Rybouchkin A, Sakata S, Nagata Y, Iida-Kobayashi M, Sekine-Kondo E, Shimizu K, Shozaki Y, Sharif J, Matsuda M, Mochiduki S, Hasegawa T, Kitahara G, Endo TA, Toyoda T, Ohara O, Harigaya K, Koseki H, Taniguchi M. Murine induced pluripotent stem cells can be derived from and differentiate into natural killer T cells. J Clin Invest 2010;120:2610-8. [PMID: 20516640 DOI: 10.1172/JCI42027] [Cited by in Crossref: 40] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
135 Okita K, Yamanaka S. Induced pluripotent stem cells: opportunities and challenges. Philos Trans R Soc Lond B Biol Sci. 2011;366:2198-2207. [PMID: 21727125 DOI: 10.1098/rstb.2011.0016] [Cited by in Crossref: 169] [Cited by in F6Publishing: 149] [Article Influence: 16.9] [Reference Citation Analysis]
136 Al-khawaga S, Memon B, Butler AE, Taheri S, Abou-samra AB, Abdelalim EM. Pathways governing development of stem cell-derived pancreatic β cells: lessons from embryogenesis: Development of pancreatic β cells. Biol Rev 2018;93:364-89. [DOI: 10.1111/brv.12349] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
137 Hoffmann A, Ziller M, Spengler D. Childhood-Onset Schizophrenia: Insights from Induced Pluripotent Stem Cells. Int J Mol Sci 2018;19:E3829. [PMID: 30513688 DOI: 10.3390/ijms19123829] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
138 Wu D, Chen X, Sheng Q, Chen W, Zhang Y, Wu F. Production of Functional Hepatobiliary Organoids from Human Pluripotent Stem Cells. Int J Stem Cells 2021;14:119-26. [PMID: 33377458 DOI: 10.15283/ijsc20152] [Reference Citation Analysis]
139 Burridge PW, Thompson S, Millrod MA, Weinberg S, Yuan X, Peters A, Mahairaki V, Koliatsos VE, Tung L, Zambidis ET. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One. 2011;6:e18293. [PMID: 21494607 DOI: 10.1371/journal.pone.0018293] [Cited by in Crossref: 286] [Cited by in F6Publishing: 253] [Article Influence: 28.6] [Reference Citation Analysis]
140 Cherry AB, Daley GQ. Reprogrammed cells for disease modeling and regenerative medicine. Annu Rev Med 2013;64:277-90. [PMID: 23327523 DOI: 10.1146/annurev-med-050311-163324] [Cited by in Crossref: 95] [Cited by in F6Publishing: 85] [Article Influence: 11.9] [Reference Citation Analysis]
141 Hayes M, Curley G, Ansari B, Laffey JG. Clinical review: Stem cell therapies for acute lung injury/acute respiratory distress syndrome - hope or hype? Crit Care 2012;16:205. [PMID: 22424108 DOI: 10.1186/cc10570] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 5.9] [Reference Citation Analysis]
142 Coyle R, Jia J, Mei Y. Polymer microarray technology for stem cell engineering. Acta Biomater 2016;34:60-72. [PMID: 26497624 DOI: 10.1016/j.actbio.2015.10.030] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
143 Yanagihara K, Liu Y, Kanie K, Takayama K, Kokunugi M, Hirata M, Fukuda T, Suga M, Nikawa H, Mizuguchi H, Kato R, Furue MK. Prediction of Differentiation Tendency Toward Hepatocytes from Gene Expression in Undifferentiated Human Pluripotent Stem Cells. Stem Cells Dev. 2016;25:1884-1897. [PMID: 27733097 DOI: 10.1089/scd.2016.0099] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
144 Morizane A, Doi D, Kikuchi T, Nishimura K, Takahashi J. Small-molecule inhibitors of bone morphogenic protein and activin/nodal signals promote highly efficient neural induction from human pluripotent stem cells. J Neurosci Res. 2011;89:117-126. [PMID: 21162120 DOI: 10.1002/jnr.22547] [Cited by in Crossref: 114] [Cited by in F6Publishing: 95] [Article Influence: 10.4] [Reference Citation Analysis]
145 Kim DS, Lee DR, Kim HS, Yoo JE, Jung SJ, Lim BY, Jang J, Kang HC, You S, Hwang DY, Leem JW, Nam TS, Cho SR, Kim DW. Highly pure and expandable PSA-NCAM-positive neural precursors from human ESC and iPSC-derived neural rosettes. PLoS One 2012;7:e39715. [PMID: 22911689 DOI: 10.1371/journal.pone.0039715] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
146 Childs AJ, Saunders PT, Anderson RA. Modelling germ cell development in vitro. Mol Hum Reprod 2008;14:501-11. [PMID: 18676971 DOI: 10.1093/molehr/gan042] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
147 Asplund A, Pradip A, van Giezen M, Aspegren A, Choukair H, Rehnström M, Jacobsson S, Ghosheh N, El Hajjam D, Holmgren S, Larsson S, Benecke J, Butron M, Wigander A, Noaksson K, Sartipy P, Björquist P, Edsbagge J, Küppers-Munther B. One Standardized Differentiation Procedure Robustly Generates Homogenous Hepatocyte Cultures Displaying Metabolic Diversity from a Large Panel of Human Pluripotent Stem Cells. Stem Cell Rev Rep 2016;12:90-104. [PMID: 26385115 DOI: 10.1007/s12015-015-9621-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
148 Huo JS, Baylin SB, Zambidis ET. Cancer-like epigenetic derangements of human pluripotent stem cells and their impact on applications in regeneration and repair. Curr Opin Genet Dev 2014;28:43-9. [PMID: 25461449 DOI: 10.1016/j.gde.2014.09.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
149 Pavlovic BJ, Blake LE, Roux J, Chavarria C, Gilad Y. A Comparative Assessment of Human and Chimpanzee iPSC-derived Cardiomyocytes with Primary Heart Tissues. Sci Rep 2018;8:15312. [PMID: 30333510 DOI: 10.1038/s41598-018-33478-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 10.3] [Reference Citation Analysis]
150 Grigoriadis AE, Kennedy M, Bozec A, Brunton F, Stenbeck G, Park IH, Wagner EF, Keller GM. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood. 2010;115:2769-2776. [PMID: 20065292 DOI: 10.1182/blood-2009-07-234690] [Cited by in Crossref: 106] [Cited by in F6Publishing: 90] [Article Influence: 9.6] [Reference Citation Analysis]
151 Nakamura K, Hirano K, Wu SM. iPS cell modeling of cardiometabolic diseases. J Cardiovasc Transl Res 2013;6:46-53. [PMID: 23070616 DOI: 10.1007/s12265-012-9413-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
152 Athanasiou KA, Darling EM, Hu JC. Articular Cartilage Tissue Engineering. Synthesis Lectures on Tissue Engineering 2009;1:1-182. [DOI: 10.2200/s00212ed1v01y200910tis003] [Cited by in Crossref: 28] [Article Influence: 2.3] [Reference Citation Analysis]
153 Abdelalim EM, Emara MM. Pluripotent Stem Cell-Derived Pancreatic β Cells: From In Vitro Maturation to Clinical Application. In: Abdelalim EM, editor. Recent Advances in Stem Cells. Cham: Springer International Publishing; 2016. pp. 101-29. [DOI: 10.1007/978-3-319-33270-3_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
154 Hanna J, Cheng AW, Saha K, Kim J, Lengner CJ, Soldner F, Cassady JP, Muffat J, Carey BW, Jaenisch R. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci USA. 2010;107:9222-9227. [PMID: 20442331 DOI: 10.1073/pnas.1004584107] [Cited by in Crossref: 612] [Cited by in F6Publishing: 545] [Article Influence: 55.6] [Reference Citation Analysis]
155 Liew CG, Andrews PW. Stem cell therapy to treat diabetes mellitus. Rev Diabet Stud 2008;5:203-19. [PMID: 19290381 DOI: 10.1900/RDS.2008.5.203] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
156 Ye L, Zhang S, Greder L, Dutton J, Keirstead SA, Lepley M, Zhang L, Kaufman D, Zhang J. Effective cardiac myocyte differentiation of human induced pluripotent stem cells requires VEGF. PLoS One 2013;8:e53764. [PMID: 23326500 DOI: 10.1371/journal.pone.0053764] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 5.5] [Reference Citation Analysis]
157 Klein M, Onnink M, van Donkelaar M, Wolfers T, Harich B, Shi Y, Dammers J, Arias-Vásquez A, Hoogman M, Franke B. Brain imaging genetics in ADHD and beyond - Mapping pathways from gene to disorder at different levels of complexity. Neurosci Biobehav Rev 2017;80:115-55. [PMID: 28159610 DOI: 10.1016/j.neubiorev.2017.01.013] [Cited by in Crossref: 47] [Cited by in F6Publishing: 29] [Article Influence: 11.8] [Reference Citation Analysis]
158 Ortmann D, Brown S, Czechanski A, Aydin S, Muraro D, Huang Y, Tomaz RA, Osnato A, Canu G, Wesley BT, Skelly DA, Stegle O, Choi T, Churchill GA, Baker CL, Rugg-Gunn PJ, Munger SC, Reinholdt LG, Vallier L. Naive Pluripotent Stem Cells Exhibit Phenotypic Variability that Is Driven by Genetic Variation. Cell Stem Cell 2020;27:470-481.e6. [PMID: 32795399 DOI: 10.1016/j.stem.2020.07.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 13.0] [Reference Citation Analysis]
159 Prilutsky D, Palmer NP, Smedemark-Margulies N, Schlaeger TM, Margulies DM, Kohane IS. iPSC-derived neurons as a higher-throughput readout for autism: promises and pitfalls. Trends Mol Med 2014;20:91-104. [PMID: 24374161 DOI: 10.1016/j.molmed.2013.11.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
160 Arora N, Daley GQ. Pluripotent stem cells in research and treatment of hemoglobinopathies. Cold Spring Harb Perspect Med 2012;2:a011841. [PMID: 22474618 DOI: 10.1101/cshperspect.a011841] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
161 Mawaribuchi S, Aiki Y, Ikeda N, Ito Y. mRNA and miRNA expression profiles in an ectoderm-biased substate of human pluripotent stem cells. Sci Rep 2019;9:11910. [PMID: 31417139 DOI: 10.1038/s41598-019-48447-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
162 de Peppo GM, Marolt D. State of the art in stem cell research: human embryonic stem cells, induced pluripotent stem cells, and transdifferentiation. J Blood Transfus 2012;2012:317632. [PMID: 24089646 DOI: 10.1155/2012/317632] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
163 Litterman NK, Ekins S. Databases and collaboration require standards for human stem cell research. Drug Discov Today 2015;20:247-54. [PMID: 25449658 DOI: 10.1016/j.drudis.2014.10.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
164 Hemmi N, Tohyama S, Nakajima K, Kanazawa H, Suzuki T, Hattori F, Seki T, Kishino Y, Hirano A, Okada M, Tabei R, Ohno R, Fujita C, Haruna T, Yuasa S, Sano M, Fujita J, Fukuda K. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes. Stem Cells Transl Med. 2014;3:1473-1483. [PMID: 25355733 DOI: 10.5966/sctm.2014-0072] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 6.7] [Reference Citation Analysis]
165 Lim CS, Yang JE, Lee YK, Lee K, Lee JA, Kaang BK. Understanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients. Mol Brain 2015;8:57. [PMID: 26419846 DOI: 10.1186/s13041-015-0146-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
166 Takahashi K, Yamanaka S. A decade of transcription factor-mediated reprogramming to pluripotency. Nat Rev Mol Cell Biol. 2016;17:183-193. [PMID: 26883003 DOI: 10.1038/nrm.2016.8] [Cited by in Crossref: 424] [Cited by in F6Publishing: 322] [Article Influence: 84.8] [Reference Citation Analysis]
167 Terryn J, Tricot T, Gajjar M, Verfaillie C. Recent advances in lineage differentiation from stem cells: hurdles and opportunities? F1000Res 2018;7:220. [PMID: 29552337 DOI: 10.12688/f1000research.12596.1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
168 Blazeski A, Zhu R, Hunter DW, Weinberg SH, Boheler KR, Zambidis ET, Tung L. Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells. Prog Biophys Mol Biol. 2012;110:178-195. [PMID: 22958937 DOI: 10.1016/j.pbiomolbio.2012.07.012] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
169 Weinberger L, Ayyash M, Novershtern N, Hanna JH. Dynamic stem cell states: naive to primed pluripotency in rodents and humans. Nat Rev Mol Cell Biol. 2016;17:155-169. [PMID: 26860365 DOI: 10.1038/nrm.2015.28] [Cited by in Crossref: 313] [Cited by in F6Publishing: 246] [Article Influence: 62.6] [Reference Citation Analysis]
170 Wei R, Yang J, Liu G, Gao M, Hou W, Zhang L, Gao H, Liu Y, Chen G, Hong T. Dynamic expression of microRNAs during the differentiation of human embryonic stem cells into insulin-producing cells. Gene 2013;518:246-55. [DOI: 10.1016/j.gene.2013.01.038] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
171 Ricordi C, Edlund H. Toward a renewable source of pancreatic β-cells. Nat Biotechnol 2008;26:397-8. [DOI: 10.1038/nbt0408-397] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
172 Świerczek B, Ciemerych MA, Archacka K. From pluripotency to myogenesis: a multistep process in the dish. J Muscle Res Cell Motil 2015;36:363-75. [PMID: 26715014 DOI: 10.1007/s10974-015-9436-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
173 Taei A, Gourabi H, Seifinejad A, Totonchi M, Shahbazi E, Valojerdi MR, Eftekhari P, Karimian L, Baharvand H. Derivation of new human embryonic stem cell lines from preimplantation genetic screening and diagnosis-analyzed embryos. In Vitro Cell Dev Biol -Animal 2010;46:395-402. [DOI: 10.1007/s11626-010-9293-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
174 Yoon CH, Kim TW, Koh SJ, Choi YE, Hur J, Kwon YW, Cho HJ, Kim HS. Gata6 in pluripotent stem cells enhance the potential to differentiate into cardiomyocytes. BMB Rep 2018;51:85-91. [PMID: 29335067 DOI: 10.5483/bmbrep.2018.51.2.176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
175 Nishino K, Arai Y, Takasawa K, Toyoda M, Yamazaki-Inoue M, Sugawara T, Akutsu H, Nishimura K, Ohtaka M, Nakanishi M, Umezawa A. Epigenetic-scale comparison of human iPSCs generated by retrovirus, Sendai virus or episomal vectors. Regen Ther 2018;9:71-8. [PMID: 30525077 DOI: 10.1016/j.reth.2018.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
176 Melo-braga MN, Meyer M, Zeng X, Larsen MR. Characterization of human neural differentiation from pluripotent stem cells using proteomics/PTMomics-Current state-of-the-art and challenges. Proteomics 2015;15:656-74. [DOI: 10.1002/pmic.201400388] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
177 Pellegrini S, Ungaro F, Mercalli A, Melzi R, Sebastiani G, Dotta F, Broccoli V, Piemonti L, Sordi V. Human induced pluripotent stem cells differentiate into insulin-producing cells able to engraft in vivo. Acta Diabetol 2015;52:1025-35. [DOI: 10.1007/s00592-015-0726-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
178 Di Giorgio FP, Boulting GL, Bobrowicz S, Eggan KC. Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell. 2008;3:637-648. [PMID: 19041780 DOI: 10.1016/j.stem.2008.09.017] [Cited by in Crossref: 338] [Cited by in F6Publishing: 317] [Article Influence: 28.2] [Reference Citation Analysis]
179 Falk A, Koch P, Kesavan J, Takashima Y, Ladewig J, Alexander M, Wiskow O, Tailor J, Trotter M, Pollard S, Smith A, Brüstle O. Capture of neuroepithelial-like stem cells from pluripotent stem cells provides a versatile system for in vitro production of human neurons. PLoS One 2012;7:e29597. [PMID: 22272239 DOI: 10.1371/journal.pone.0029597] [Cited by in Crossref: 185] [Cited by in F6Publishing: 168] [Article Influence: 20.6] [Reference Citation Analysis]
180 Yechoor V, Chan L. Minireview: beta-cell replacement therapy for diabetes in the 21st century: manipulation of cell fate by directed differentiation. Mol Endocrinol 2010;24:1501-11. [PMID: 20219891 DOI: 10.1210/me.2009-0311] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
181 Takasato M, Er PX, Chiu HS, Little MH. Generation of kidney organoids from human pluripotent stem cells. Nat Protoc. 2016;11:1681-1692. [PMID: 27560173 DOI: 10.1038/nprot.2016.098] [Cited by in Crossref: 133] [Cited by in F6Publishing: 103] [Article Influence: 26.6] [Reference Citation Analysis]
182 Rhee YH, Puspita L, Sulistio YA, Kim SW, Vidyawan V, Elvira R, Chang MY, Shim JW, Lee SH. Efficient Neural Differentiation of hPSCs by Extrinsic Signals Derived from Co-cultured Neural Stem or Precursor Cells. Mol Ther 2019;27:1299-312. [PMID: 31043343 DOI: 10.1016/j.ymthe.2019.04.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
183 Mishra S, Taelman J, Popovic M, Tilleman L, Duthoo E, van der Jeught M, Deforce D, van Nieuwerburgh F, Menten B, de Sutter P, Boel A, Chuva De Sousa Lopes SM, Heindryckx B. Activin A-derived human embryonic stem cells show increased competence to differentiate into primordial germ cell-like cells. Stem Cells 2021;39:551-63. [PMID: 33470497 DOI: 10.1002/stem.3335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
184 Giritharan G, Ilic D, Gormley M, Krtolica A. Human embryonic stem cells derived from embryos at different stages of development share similar transcription profiles. PLoS One 2011;6:e26570. [PMID: 22039509 DOI: 10.1371/journal.pone.0026570] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
185 Li QV, Dixon G, Verma N, Rosen BP, Gordillo M, Luo R, Xu C, Wang Q, Soh CL, Yang D, Crespo M, Shukla A, Xiang Q, Dündar F, Zumbo P, Witkin M, Koche R, Betel D, Chen S, Massagué J, Garippa R, Evans T, Beer MA, Huangfu D. Genome-scale screens identify JNK-JUN signaling as a barrier for pluripotency exit and endoderm differentiation. Nat Genet 2019;51:999-1010. [PMID: 31110351 DOI: 10.1038/s41588-019-0408-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 17.0] [Reference Citation Analysis]
186 Cahan P, Cacchiarelli D, Dunn SJ, Hemberg M, de Sousa Lopes SMC, Morris SA, Rackham OJL, Del Sol A, Wells CA. Computational Stem Cell Biology: Open Questions and Guiding Principles. Cell Stem Cell 2021;28:20-32. [PMID: 33417869 DOI: 10.1016/j.stem.2020.12.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
187 Toyohara T, Mae S, Sueta S, Inoue T, Yamagishi Y, Kawamoto T, Kasahara T, Hoshina A, Toyoda T, Tanaka H, Araoka T, Sato-Otsubo A, Takahashi K, Sato Y, Yamaji N, Ogawa S, Yamanaka S, Osafune K. Cell Therapy Using Human Induced Pluripotent Stem Cell-Derived Renal Progenitors Ameliorates Acute Kidney Injury in Mice. Stem Cells Transl Med. 2015;4:980-992. [PMID: 26198166 DOI: 10.5966/sctm.2014-0219] [Cited by in Crossref: 87] [Cited by in F6Publishing: 71] [Article Influence: 14.5] [Reference Citation Analysis]
188 Maehr R. iPS Cells in Type 1 Diabetes Research and Treatment. Clin Pharmacol Ther 2011;89:750-3. [DOI: 10.1038/clpt.2011.1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
189 Brafman DA, Phung C, Kumar N, Willert K. Regulation of endodermal differentiation of human embryonic stem cells through integrin-ECM interactions. Cell Death Differ. 2013;20:369-381. [PMID: 23154389 DOI: 10.1038/cdd.2012.138] [Cited by in Crossref: 78] [Cited by in F6Publishing: 70] [Article Influence: 8.7] [Reference Citation Analysis]
190 Fraga AM, Souza de Araújo ÉS, Stabellini R, Vergani N, Pereira LV. A survey of parameters involved in the establishment of new lines of human embryonic stem cells. Stem Cell Rev Rep 2011;7:775-81. [PMID: 21416256 DOI: 10.1007/s12015-011-9250-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
191 Nichols J, Smith A. Pluripotency in the embryo and in culture. Cold Spring Harb Perspect Biol 2012;4:a008128. [PMID: 22855723 DOI: 10.1101/cshperspect.a008128] [Cited by in Crossref: 186] [Cited by in F6Publishing: 151] [Article Influence: 20.7] [Reference Citation Analysis]
192 Osafune K. In vitro regeneration of kidney from pluripotent stem cells. Exp Cell Res 2010;316:2571-7. [PMID: 20451514 DOI: 10.1016/j.yexcr.2010.04.034] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
193 Albalushi H, Kurek M, Karlsson L, Landreh L, Kjartansdóttir KR, Söder O, Hovatta O, Stukenborg JB. Laminin 521 Stabilizes the Pluripotency Expression Pattern of Human Embryonic Stem Cells Initially Derived on Feeder Cells. Stem Cells Int 2018;2018:7127042. [PMID: 29535778 DOI: 10.1155/2018/7127042] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
194 Lock LT, Tzanakakis ES. Expansion and differentiation of human embryonic stem cells to endoderm progeny in a microcarrier stirred-suspension culture. Tissue Eng Part A. 2009;15:2051-2063. [PMID: 19196140 DOI: 10.1089/ten.tea.2008.0455] [Cited by in Crossref: 146] [Cited by in F6Publishing: 126] [Article Influence: 12.2] [Reference Citation Analysis]
195 Dong C, Fischer LA, Theunissen TW. Recent insights into the naïve state of human pluripotency and its applications. Experimental Cell Research 2019;385:111645. [DOI: 10.1016/j.yexcr.2019.111645] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
196 Davaapil H, Shetty DK, Sinha S. Aortic "Disease-in-a-Dish": Mechanistic Insights and Drug Development Using iPSC-Based Disease Modeling. Front Cell Dev Biol 2020;8:550504. [PMID: 33195187 DOI: 10.3389/fcell.2020.550504] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
197 Prajapati C, Ojala M, Lappi H, Aalto-Setälä K, Pekkanen-Mattila M. Electrophysiological evaluation of human induced pluripotent stem cell-derived cardiomyocytes obtained by different methods. Stem Cell Res 2021;51:102176. [PMID: 33485184 DOI: 10.1016/j.scr.2021.102176] [Reference Citation Analysis]
198 Cheung AY, Horvath LM, Grafodatskaya D, Pasceri P, Weksberg R, Hotta A, Carrel L, Ellis J. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum Mol Genet. 2011;20:2103-2115. [PMID: 21372149 DOI: 10.1093/hmg/ddr093] [Cited by in Crossref: 195] [Cited by in F6Publishing: 175] [Article Influence: 19.5] [Reference Citation Analysis]
199 Erdélyi-Belle B, Török G, Apáti Á, Sarkadi B, Schaff Z, Kiss A, Homolya L. Expression of Tight Junction Components in Hepatocyte-Like Cells Differentiated from Human Embryonic Stem Cells. Pathol Oncol Res 2015;21:1059-70. [PMID: 25845432 DOI: 10.1007/s12253-015-9936-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
200 Lupo G, Bertacchi M, Carucci N, Augusti-Tocco G, Biagioni S, Cremisi F. From pluripotency to forebrain patterning: an in vitro journey astride embryonic stem cells. Cell Mol Life Sci 2014;71:2917-30. [PMID: 24643740 DOI: 10.1007/s00018-014-1596-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
201 Saeki K, Saeki K, Nakahara M, Matsuyama S, Nakamura N, Yogiashi Y, Yoneda A, Koyanagi M, Kondo Y, Yuo A. A feeder-free and efficient production of functional neutrophils from human embryonic stem cells. Stem Cells 2009;27:59-67. [PMID: 18845766 DOI: 10.1634/stemcells.2007-0980] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
202 Lee YXF, Johansson H, Wood MJA, El Andaloussi S. Considerations and Implications in the Purification of Extracellular Vesicles - A Cautionary Tale. Front Neurosci 2019;13:1067. [PMID: 31680809 DOI: 10.3389/fnins.2019.01067] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
203 Shelton M, Kocharyan A, Liu J, Skerjanc IS, Stanford WL. Robust generation and expansion of skeletal muscle progenitors and myocytes from human pluripotent stem cells. Methods 2016;101:73-84. [PMID: 26404920 DOI: 10.1016/j.ymeth.2015.09.019] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
204 Ávila-González D, García-López G, García-Castro IL, Flores-Herrera H, Molina-Hernández A, Portillo W, Díaz NF. Capturing the ephemeral human pluripotent state. Dev Dyn 2016;245:762-73. [PMID: 27004967 DOI: 10.1002/dvdy.24405] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
205 Yassa ME, Mansour IA, Sewelam NI, Hamza H, Gaafar T. The impact of growth factors on human induced pluripotent stem cells differentiation into cardiomyocytes. Life Sciences 2018;196:38-47. [DOI: 10.1016/j.lfs.2018.01.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
206 Yamanaka S. Pluripotent Stem Cell-Based Cell Therapy-Promise and Challenges. Cell Stem Cell. 2020;27:523-531. [PMID: 33007237 DOI: 10.1016/j.stem.2020.09.014] [Cited by in Crossref: 51] [Cited by in F6Publishing: 38] [Article Influence: 51.0] [Reference Citation Analysis]
207 Chan SS, Shi X, Toyama A, Arpke RW, Dandapat A, Iacovino M, Kang J, Le G, Hagen HR, Garry DJ, Kyba M. Mesp1 patterns mesoderm into cardiac, hematopoietic, or skeletal myogenic progenitors in a context-dependent manner. Cell Stem Cell 2013;12:587-601. [PMID: 23642367 DOI: 10.1016/j.stem.2013.03.004] [Cited by in Crossref: 121] [Cited by in F6Publishing: 101] [Article Influence: 17.3] [Reference Citation Analysis]
208 Kaupisch A, Kennedy L, Stelmanis V, Tye B, Kane NM, Mountford JC, Courtney A, Baker AH. Derivation of vascular endothelial cells from human embryonic stem cells under GMP-compliant conditions: towards clinical studies in ischaemic disease. J Cardiovasc Transl Res 2012;5:605-17. [PMID: 22855254 DOI: 10.1007/s12265-012-9379-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
209 Moon SH, Kim SW, Kim JS, Park SJ, Do JT, Lee DR, Chung HM. Gene expression profiles in CHA3 and CHA4 human embryonic stem cells and embryoid bodies. Mol Cells 2011;31:315-26. [PMID: 21359678 DOI: 10.1007/s10059-011-0039-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
210 Alsanie WF, Niclis JC, Petratos S. Human embryonic stem cell-derived oligodendrocytes: protocols and perspectives. Stem Cells Dev. 2013;22:2459-2476. [PMID: 23621561 DOI: 10.1089/scd.2012.0520] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
211 Faustino Martins JM, Fischer C, Urzi A, Vidal R, Kunz S, Ruffault PL, Kabuss L, Hube I, Gazzerro E, Birchmeier C, Spuler S, Sauer S, Gouti M. Self-Organizing 3D Human Trunk Neuromuscular Organoids. Cell Stem Cell 2020;26:172-186.e6. [PMID: 31956040 DOI: 10.1016/j.stem.2019.12.007] [Cited by in Crossref: 56] [Cited by in F6Publishing: 36] [Article Influence: 56.0] [Reference Citation Analysis]
212 Wei R, Yang J, Hou W, Liu G, Gao M, Zhang L, Wang H, Mao G, Gao H, Chen G. Insulin-producing cells derived from human embryonic stem cells: comparison of definitive endoderm- and nestin-positive progenitor-based differentiation strategies. PLoS One. 2013;8:e72513. [PMID: 23951327 DOI: 10.1371/journal.pone.0072513] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
213 Wu J, Belmonte JCI. Interspecies chimeric complementation for the generation of functional human tissues and organs in large animal hosts. Transgenic Res 2016;25:375-84. [DOI: 10.1007/s11248-016-9930-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
214 Stefanova VT, Grifo JA, Hansis C. Derivation of novel genetically diverse human embryonic stem cell lines. Stem Cells Dev 2012;21:1559-70. [PMID: 22204497 DOI: 10.1089/scd.2011.0642] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
215 Zhang D, Jiang W. From One-Cell to Tissue: Reprogramming, Cell Differentiation and Tissue Engineering. BioScience 2015;65:468-75. [DOI: 10.1093/biosci/biv016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
216 Bellin M, Marchetto MC, Gage FH, Mummery CL. Induced pluripotent stem cells: the new patient? Nat Rev Mol Cell Biol. 2012;13:713-726. [PMID: 23034453 DOI: 10.1038/nrm3448] [Cited by in Crossref: 293] [Cited by in F6Publishing: 259] [Article Influence: 32.6] [Reference Citation Analysis]
217 Shimojo D, Onodera K, Doi-Torii Y, Ishihara Y, Hattori C, Miwa Y, Tanaka S, Okada R, Ohyama M, Shoji M, Nakanishi A, Doyu M, Okano H, Okada Y. Rapid, efficient, and simple motor neuron differentiation from human pluripotent stem cells. Mol Brain 2015;8:79. [PMID: 26626025 DOI: 10.1186/s13041-015-0172-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 8.3] [Reference Citation Analysis]
218 Mattioli M, Gloria A, Turriani M, Mauro A, Curini V, Russo V, Tetè S, Marchisio M, Pierdomenico L, Berardinelli P. Stemness characteristics and osteogenic potential of sheep amniotic epithelial cells. Cell Biol Int. 2012;36:7-19. [PMID: 21880014 DOI: 10.1042/cbi20100720] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
219 Pistollato F, Bremer-Hoffmann S, Healy L, Young L, Stacey G. Standardization of pluripotent stem cell cultures for toxicity testing. Expert Opin Drug Metab Toxicol 2012;8:239-57. [PMID: 22248265 DOI: 10.1517/17425255.2012.639763] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
220 Osafune K. iPS cell technology-based research for the treatment of diabetic nephropathy. Semin Nephrol 2012;32:479-85. [PMID: 23062989 DOI: 10.1016/j.semnephrol.2012.07.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
221 Fenno LE, Ptaszek LM, Cowan CA. Human embryonic stem cells: emerging technologies and practical applications. Current Opinion in Genetics & Development 2008;18:324-9. [DOI: 10.1016/j.gde.2008.06.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
222 Taelman J, Popovic M, Bialecka M, Tilleman L, Warrier S, Van Der Jeught M, Menten B, Deforce D, De Sutter P, Van Nieuwerburgh F, Abe K, Heindryckx B, Chuva de Sousa Lopes SM. WNT Inhibition and Increased FGF Signaling Promotes Derivation of Less Heterogeneous Primed Human Embryonic Stem Cells, Compatible with Differentiation. Stem Cells Dev 2019;28:579-92. [PMID: 30827199 DOI: 10.1089/scd.2018.0199] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
223 Sherman SP, Pyle AD. Small molecule screening with laser cytometry can be used to identify pro-survival molecules in human embryonic stem cells. PLoS One 2013;8:e54948. [PMID: 23383009 DOI: 10.1371/journal.pone.0054948] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
224 Melichar H, Li O, Ross J, Haber H, Cado D, Nolla H, Robey EA, Winoto A. Comparative study of hematopoietic differentiation between human embryonic stem cell lines. PLoS One 2011;6:e19854. [PMID: 21603627 DOI: 10.1371/journal.pone.0019854] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
225 Vallier L. Serum-free and feeder-free culture conditions for human embryonic stem cells. Methods Mol Biol 2011;690:57-66. [PMID: 21042984 DOI: 10.1007/978-1-60761-962-8_3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
226 Sullivan GJ, Bai Y, Fletcher J, Wilmut I. Induced pluripotent stem cells: epigenetic memories and practical implications. Mol Hum Reprod 2010;16:880-5. [PMID: 21059705 DOI: 10.1093/molehr/gaq091] [Cited by in Crossref: 52] [Cited by in F6Publishing: 38] [Article Influence: 4.7] [Reference Citation Analysis]
227 Kane NM, Howard L, Descamps B, Meloni M, McClure J, Lu R, McCahill A, Breen C, Mackenzie RM, Delles C. Role of microRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells. Stem Cells. 2012;30:643-654. [PMID: 22232059 DOI: 10.1002/stem.1026] [Cited by in Crossref: 79] [Cited by in F6Publishing: 68] [Article Influence: 8.8] [Reference Citation Analysis]
228 Saitoh I, Sato M, Iwase Y, Inada E, Nomura T, Akasaka E, Yamasaki Y, Noguchi H. Generation of Mouse STO Feeder Cell Lines That Confer Resistance to Several Types of Selective Drugs. Cell Med 2012;3:97-102. [PMID: 28058186 DOI: 10.3727/215517912X639414] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
229 Nishikawa S, Goldstein RA, Nierras CR. The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol 2008;9:725-9. [PMID: 18698329 DOI: 10.1038/nrm2466] [Cited by in Crossref: 313] [Cited by in F6Publishing: 265] [Article Influence: 24.1] [Reference Citation Analysis]
230 Kugler J, Huhse B, Tralau T, Luch A. Embryonic stem cells and the next generation of developmental toxicity testing. Expert Opin Drug Metab Toxicol 2017;13:833-41. [PMID: 28675072 DOI: 10.1080/17425255.2017.1351548] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
231 Ikonomou L, Kotton DN. Derivation of Endodermal Progenitors From Pluripotent Stem Cells. J Cell Physiol 2015;230:246-58. [PMID: 25160562 DOI: 10.1002/jcp.24771] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
232 Viventi S, Dottori M. Modelling the dorsal root ganglia using human pluripotent stem cells: A platform to study peripheral neuropathies. Int J Biochem Cell Biol 2018;100:61-8. [PMID: 29772357 DOI: 10.1016/j.biocel.2018.05.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
233 Srikanth P, Young-Pearse TL. Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells. J Neurogenet 2014;28:5-29. [PMID: 24628482 DOI: 10.3109/01677063.2014.881358] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 6.1] [Reference Citation Analysis]
234 Razak SR, Ueno K, Takayama N, Nariai N, Nagasaki M, Saito R, Koso H, Lai CY, Murakami M, Tsuji K, Michiue T, Nakauchi H, Otsu M, Watanabe S. Profiling of microRNA in human and mouse ES and iPS cells reveals overlapping but distinct microRNA expression patterns. PLoS One 2013;8:e73532. [PMID: 24086284 DOI: 10.1371/journal.pone.0073532] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
235 Nakahara M, Nakamura N, Matsuyama S, Yogiashi Y, Yasuda K, Kondo Y, Yuo A, Saeki K. High-efficiency production of subculturable vascular endothelial cells from feeder-free human embryonic stem cells without cell-sorting technique. Cloning Stem Cells. 2009;11:509-522. [PMID: 20025522 DOI: 10.1089/clo.2009.0023] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
236 Pekkanen-Mattila M, Pelto-Huikko M, Kujala V, Suuronen R, Skottman H, Aalto-Setälä K, Kerkelä E. Spatial and temporal expression pattern of germ layer markers during human embryonic stem cell differentiation in embryoid bodies. Histochem Cell Biol 2010;133:595-606. [PMID: 20369364 DOI: 10.1007/s00418-010-0689-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
237 Schwartz PH, Brick DJ, Stover AE, Loring JF, Müller FJ. Differentiation of neural lineage cells from human pluripotent stem cells. Methods 2008;45:142-58. [PMID: 18593611 DOI: 10.1016/j.ymeth.2008.03.007] [Cited by in Crossref: 60] [Cited by in F6Publishing: 48] [Article Influence: 4.6] [Reference Citation Analysis]
238 Ilancheran S, Moodley Y, Manuelpillai U. Human fetal membranes: a source of stem cells for tissue regeneration and repair? Placenta. 2009;30:2-10. [PMID: 18995896 DOI: 10.1016/j.placenta.2008.09.009] [Cited by in Crossref: 172] [Cited by in F6Publishing: 151] [Article Influence: 13.2] [Reference Citation Analysis]
239 Kotaka M, Toyoda T, Yasuda K, Kitano Y, Okada C, Ohta A, Watanabe A, Uesugi M, Osafune K. Adrenergic receptor agonists induce the differentiation of pluripotent stem cell-derived hepatoblasts into hepatocyte-like cells. Sci Rep 2017;7:16734. [PMID: 29196668 DOI: 10.1038/s41598-017-16858-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
240 Pal R, Totey S, Mamidi MK, Bhat VS, Totey S. Propensity of human embryonic stem cell lines during early stage of lineage specification controls their terminal differentiation into mature cell types. Exp Biol Med (Maywood) 2009;234:1230-43. [PMID: 19546356 DOI: 10.3181/0901-RM-38] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
241 Maehr R, Chen S, Snitow M, Ludwig T, Yagasaki L, Goland R, Leibel RL, Melton DA. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci USA. 2009;106:15768-15773. [PMID: 19720998 DOI: 10.1073/pnas.0906894106] [Cited by in Crossref: 403] [Cited by in F6Publishing: 333] [Article Influence: 33.6] [Reference Citation Analysis]
242 Schäfer R. Does the adult stroma contain stem cells? Adv Biochem Eng Biotechnol 2013;129:177-89. [PMID: 23117643 DOI: 10.1007/10_2012_160] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
243 Scesa G, Adami R, Bottai D. iPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter? Cells 2021;10:1470. [PMID: 34208270 DOI: 10.3390/cells10061470] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
244 Teo AK, Ali Y, Wong KY, Chipperfield H, Sadasivam A, Poobalan Y, Tan EK, Wang ST, Abraham S, Tsuneyoshi N, Stanton LW, Dunn NR. Activin and BMP4 synergistically promote formation of definitive endoderm in human embryonic stem cells. Stem Cells 2012;30:631-42. [PMID: 22893457 DOI: 10.1002/stem.1022] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 8.9] [Reference Citation Analysis]
245 Tahamtani Y, Azarnia M, Farrokhi A, Sharifi-Zarchi A, Aghdami N, Baharvand H. Treatment of human embryonic stem cells with different combinations of priming and inducing factors toward definitive endoderm. Stem Cells Dev. 2013;22:1419-1432. [PMID: 23249309 DOI: 10.1089/scd.2012.0453] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
246 Noguchi M, Hosoda K, Nakane M, Mori E, Nakao K, Taura D, Yamamoto Y, Kusakabe T, Sone M, Sakurai H, Fujikura J, Ebihara K. In vitro characterization and engraftment of adipocytes derived from human induced pluripotent stem cells and embryonic stem cells. Stem Cells Dev. 2013;22:2895-2905. [PMID: 23750558 DOI: 10.1089/scd.2013.0113] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
247 Rubin LL, Haston KM. Stem cell biology and drug discovery. BMC Biol 2011;9:42. [PMID: 21649940 DOI: 10.1186/1741-7007-9-42] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
248 Duggal G, Heindryckx B, Warrier S, Taelman J, Van der Jeught M, Deforce D, Chuva de Sousa Lopes S, De Sutter P. Exogenous supplementation of Activin A enhances germ cell differentiation of human embryonic stem cells. Mol Hum Reprod 2015;21:410-23. [PMID: 25634576 DOI: 10.1093/molehr/gav004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
249 Faradonbeh MZ, Gharechahi J, Mollamohammadi S, Pakzad M, Taei A, Rassouli H, Baharvand H, Salekdeh GH. An orthogonal comparison of the proteome of human embryonic stem cells with that of human induced pluripotent stem cells of different genetic background. Mol BioSyst 2012;8:1833. [DOI: 10.1039/c2mb25018g] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
250 Gu W, Gaeta X, Sahakyan A, Chan AB, Hong CS, Kim R, Braas D, Plath K, Lowry WE, Christofk HR. Glycolytic Metabolism Plays a Functional Role in Regulating Human Pluripotent Stem Cell State. Cell Stem Cell. 2016;19:476-490. [PMID: 27618217 DOI: 10.1016/j.stem.2016.08.008] [Cited by in Crossref: 145] [Cited by in F6Publishing: 116] [Article Influence: 29.0] [Reference Citation Analysis]
251 Yamanaka S. Induced pluripotent stem cells: past, present, and future. Cell Stem Cell. 2012;10:678-684. [PMID: 22704507 DOI: 10.1016/j.stem.2012.05.005] [Cited by in Crossref: 492] [Cited by in F6Publishing: 393] [Article Influence: 54.7] [Reference Citation Analysis]
252 Shahjalal HM, Abdal Dayem A, Lim KM, Jeon TI, Cho SG. Generation of pancreatic β cells for treatment of diabetes: advances and challenges. Stem Cell Res Ther 2018;9:355. [PMID: 30594258 DOI: 10.1186/s13287-018-1099-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 13.0] [Reference Citation Analysis]
253 Rhee HJ, Shaib AH, Rehbach K, Lee C, Seif P, Thomas C, Gideons E, Guenther A, Krutenko T, Hebisch M, Peitz M, Brose N, Brüstle O, Rhee JS. An Autaptic Culture System for Standardized Analyses of iPSC-Derived Human Neurons. Cell Reports 2019;27:2212-2228.e7. [DOI: 10.1016/j.celrep.2019.04.059] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 10.5] [Reference Citation Analysis]
254 Bock C, Kiskinis E, Verstappen G, Gu H, Boulting G, Smith ZD, Ziller M, Croft GF, Amoroso MW, Oakley DH, Gnirke A, Eggan K, Meissner A. Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell. 2011;144:439-452. [PMID: 21295703 DOI: 10.1016/j.cell.2010.12.032] [Cited by in Crossref: 723] [Cited by in F6Publishing: 596] [Article Influence: 72.3] [Reference Citation Analysis]
255 Kimura K, Tsukamoto M, Yoshida T, Tanaka M, Kuwamura M, Ohtaka M, Nishimura K, Nakanishi M, Sugiura K, Hatoya S. Canine induced pluripotent stem cell maintenance under feeder-free and chemically-defined conditions. Mol Reprod Dev 2021;88:395-404. [PMID: 34010985 DOI: 10.1002/mrd.23478] [Reference Citation Analysis]
256 Lukovic D, Diez Lloret A, Stojkovic P, Rodríguez-Martínez D, Perez Arago MA, Rodriguez-Jimenez FJ, González-Rodríguez P, López-Barneo J, Sykova E, Jendelova P, Kostic J, Moreno-Manzano V, Stojkovic M, Bhattacharya SS, Erceg S. Highly Efficient Neural Conversion of Human Pluripotent Stem Cells in Adherent and Animal-Free Conditions. Stem Cells Transl Med 2017;6:1217-26. [PMID: 28213969 DOI: 10.1002/sctm.16-0371] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
257 Nakahara M, Saeki K, Nakamura N, Matsuyama S, Yogiashi Y, Yasuda K, Kondo Y, Yuo A. Human Embryonic Stem Cells with Maintenance under a Feeder-Free and Recombinant Cytokine-Free Condition. Cloning and Stem Cells 2009;11:5-18. [DOI: 10.1089/clo.2008.0043] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
258 Cai Q, Bonfanti P, Sambathkumar R, Vanuytsel K, Vanhove J, Gysemans C, Debiec-Rychter M, Raitano S, Heimberg H, Ordovas L, Verfaillie CM. Prospectively isolated NGN3-expressing progenitors from human embryonic stem cells give rise to pancreatic endocrine cells. Stem Cells Transl Med 2014;3:489-99. [PMID: 24493854 DOI: 10.5966/sctm.2013-0078] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
259 Asgari S, Moslem M, Bagheri-Lankarani K, Pournasr B, Miryounesi M, Baharvand H. Differentiation and transplantation of human induced pluripotent stem cell-derived hepatocyte-like cells. Stem Cell Rev. 2013;9:493-504. [PMID: 22076752 DOI: 10.1007/s12015-011-9330-y] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 9.0] [Reference Citation Analysis]
260 Markouli C, De Deckersberg EC, Dziedzicka D, Regin M, Franck S, Keller A, Gheldof A, Geens M, Sermon K, Spits C. Sustained intrinsic WNT and BMP4 activation impairs hESC differentiation to definitive endoderm and drives the cells towards extra-embryonic mesoderm. Sci Rep 2021;11:8242. [PMID: 33859268 DOI: 10.1038/s41598-021-87547-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
261 Peters DT, Henderson CA, Warren CR, Friesen M, Xia F, Becker CE, Musunuru K, Cowan CA. Asialoglycoprotein receptor 1 is a specific cell-surface marker for isolating hepatocytes derived from human pluripotent stem cells. Development. 2016;143:1475-1481. [PMID: 27143754 DOI: 10.1242/dev.132209] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
262 Toyoda T, Mae S, Tanaka H, Kondo Y, Funato M, Hosokawa Y, Sudo T, Kawaguchi Y, Osafune K. Cell aggregation optimizes the differentiation of human ESCs and iPSCs into pancreatic bud-like progenitor cells. Stem Cell Research 2015;14:185-97. [DOI: 10.1016/j.scr.2015.01.007] [Cited by in Crossref: 69] [Cited by in F6Publishing: 52] [Article Influence: 11.5] [Reference Citation Analysis]
263 Shcherbina A, Li J, Narayanan C, Greenleaf W, Kundaje A, Chetty S. Brief Report: Cell Cycle Dynamics of Human Pluripotent Stem Cells Primed for Differentiation. Stem Cells 2019;37:1151-7. [PMID: 31135093 DOI: 10.1002/stem.3041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
264 Oliveira LM, Falomir-Lockhart LJ, Botelho MG, Lin KH, Wales P, Koch JC, Gerhardt E, Taschenberger H, Outeiro TF, Lingor P, Schüle B, Arndt-Jovin DJ, Jovin TM. Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells. Cell Death Dis 2015;6:e1994. [PMID: 26610207 DOI: 10.1038/cddis.2015.318] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 12.2] [Reference Citation Analysis]
265 Thatava T, Kudva YC, Edukulla R, Squillace K, De Lamo JG, Khan YK, Sakuma T, Ohmine S, Terzic A, Ikeda Y. Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells. Mol Ther. 2013;21:228-239. [PMID: 23183535 DOI: 10.1038/mt.2012.245] [Cited by in Crossref: 73] [Cited by in F6Publishing: 61] [Article Influence: 8.1] [Reference Citation Analysis]
266 Mikhailova A, Ilmarinen T, Uusitalo H, Skottman H. Small-molecule induction promotes corneal epithelial cell differentiation from human induced pluripotent stem cells. Stem Cell Reports 2014;2:219-31. [PMID: 24527395 DOI: 10.1016/j.stemcr.2013.12.014] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 7.6] [Reference Citation Analysis]
267 Evans AL, Dalby A, Foster HR, Howard D, Waller AK, Taimoor M, Lawrence M, Mookerjee S, Lehmann M, Burton A, Valdez J, Thon J, Italiano J, Moreau T, Ghevaert C. Transfer to the clinic: refining forward programming of hPSCs to megakaryocytes for platelet production in bioreactors. Blood Adv 2021;5:1977-90. [PMID: 33843988 DOI: 10.1182/bloodadvances.2020003236] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
268 Lysy PA, Corritore E, Sokal EM. New Insights into Diabetes Cell Therapy. Curr Diab Rep. 2016;16:38. [PMID: 26983626 DOI: 10.1007/s11892-016-0729-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
269 Wang Z, Oron E, Nelson B, Razis S, Ivanova N. Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells. Cell Stem Cell. 2012;10:440-454. [PMID: 22482508 DOI: 10.1016/j.stem.2012.02.016] [Cited by in Crossref: 342] [Cited by in F6Publishing: 290] [Article Influence: 38.0] [Reference Citation Analysis]
270 Hrvatin S, O’Donnell CW, Deng F, Millman JR, Pagliuca FW, DiIorio P, Rezania A, Gifford DK, Melton DA. Differentiated human stem cells resemble fetal, not adult, β cells. Proc Natl Acad Sci USA. 2014;111:3038-3043. [PMID: 24516164 DOI: 10.1073/pnas.1400709111] [Cited by in Crossref: 178] [Cited by in F6Publishing: 154] [Article Influence: 25.4] [Reference Citation Analysis]
271 Sandoe J, Eggan K. Opportunities and challenges of pluripotent stem cell neurodegenerative disease models. Nat Neurosci. 2013;16:780-789. [PMID: 23799470 DOI: 10.1038/nn.3425] [Cited by in Crossref: 145] [Cited by in F6Publishing: 128] [Article Influence: 18.1] [Reference Citation Analysis]
272 Kim MH, Takeuchi K, Kino-Oka M. Role of cell-secreted extracellular matrix formation in aggregate formation and stability of human induced pluripotent stem cells in suspension culture. J Biosci Bioeng 2019;127:372-80. [PMID: 30249415 DOI: 10.1016/j.jbiosc.2018.08.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
273 Nishio M, Nakahara M, Yuo A, Saeki K. Human pluripotent stem cells: Towards therapeutic development for the treatment of lifestyle diseases. World J Stem Cells 2016;8:56-61. [PMID: 26981171 DOI: 10.4252/wjsc.v8.i2.56] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
274 Saitoh I, Sato M, Soda M, Inada E, Iwase Y, Murakami T, Ohshima H, Hayasaki H, Noguchi H. Tissue-Specific Stem Cells Obtained by Reprogramming of Non-Obese Diabetic (NOD) Mouse-Derived Pancreatic Cells Confer Insulin Production in Response to Glucose. PLoS One. 2016;11:e0163580. [PMID: 27662374 DOI: 10.1371/journal.pone.0163580] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
275 Kondo Y, Toyoda T, Ito R, Funato M, Hosokawa Y, Matsui S, Sudo T, Nakamura M, Okada C, Zhuang X, Watanabe A, Ohta A, Inagaki N, Osafune K. Identification of a small molecule that facilitates the differentiation of human iPSCs/ESCs and mouse embryonic pancreatic explants into pancreatic endocrine cells. Diabetologia 2017;60:1454-66. [PMID: 28534195 DOI: 10.1007/s00125-017-4302-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
276 Wang YC, Stein JW, Lynch CL, Tran HT, Lee CY, Coleman R, Hatch A, Antontsev VG, Chy HS, O'Brien CM, Murthy SK, Laslett AL, Peterson SE, Loring JF. Glycosyltransferase ST6GAL1 contributes to the regulation of pluripotency in human pluripotent stem cells. Sci Rep 2015;5:13317. [PMID: 26304831 DOI: 10.1038/srep13317] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
277 Mohr JC, Zhang J, Azarin SM, Soerens AG, de Pablo JJ, Thomson JA, Lyons GE, Palecek SP, Kamp TJ. The microwell control of embryoid body size in order to regulate cardiac differentiation of human embryonic stem cells. Biomaterials. 2010;31:1885-1893. [PMID: 19945747 DOI: 10.1016/j.biomaterials.2009.11.033] [Cited by in Crossref: 150] [Cited by in F6Publishing: 126] [Article Influence: 12.5] [Reference Citation Analysis]
278 Diekmann U, Naujok O, Blasczyk R, Müller T. Embryonic stem cells of the non-human primate Callithrix jacchus can be differentiated into definitive endoderm by Activin-A but not IDE-1/2. J Tissue Eng Regen Med 2015;9:473-9. [PMID: 23418163 DOI: 10.1002/term.1709] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
279 Peterson QP, Veres A, Chen L, Slama MQ, Kenty JHR, Hassoun S, Brown MR, Dou H, Duffy CD, Zhou Q, Matveyenko AV, Tyrberg B, Sörhede-Winzell M, Rorsman P, Melton DA. A method for the generation of human stem cell-derived alpha cells. Nat Commun 2020;11:2241. [PMID: 32382023 DOI: 10.1038/s41467-020-16049-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 21.0] [Reference Citation Analysis]
280 Gundry RL, Riordon DR, Tarasova Y, Chuppa S, Bhattacharya S, Juhasz O, Wiedemeier O, Milanovich S, Noto FK, Tchernyshyov I, Raginski K, Bausch-Fluck D, Tae HJ, Marshall S, Duncan SA, Wollscheid B, Wersto RP, Rao S, Van Eyk JE, Boheler KR. A cell surfaceome map for immunophenotyping and sorting pluripotent stem cells. Mol Cell Proteomics 2012;11:303-16. [PMID: 22493178 DOI: 10.1074/mcp.M112.018135] [Cited by in Crossref: 45] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
281 Dajani R, Koo SE, Sullivan GJ, Park IH. Investigation of Rett syndrome using pluripotent stem cells. J Cell Biochem 2013;114:2446-53. [PMID: 23744605 DOI: 10.1002/jcb.24597] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
282 Williams EO, Taylor AK, Bell EL, Lim R, Kim DM, Guarente L. Sirtuin 1 Promotes Deacetylation of Oct4 and Maintenance of Naive Pluripotency. Cell Rep 2016;17:809-20. [PMID: 27732856 DOI: 10.1016/j.celrep.2016.09.046] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
283 Zhao Z, Ma Y, Chen Z, Liu Q, Li Q, Kong D, Yuan K, Hu L, Wang T, Chen X, Peng Y, Jiang W, Yu Y, Liu X. Effects of Feeder Cells on Dopaminergic Differentiation of Human Embryonic Stem Cells. Front Cell Neurosci 2016;10:291. [PMID: 28066186 DOI: 10.3389/fncel.2016.00291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
284 Lu HF, Lim SX, Leong MF, Narayanan K, Toh RP, Gao S, Wan AC. Efficient neuronal differentiation and maturation of human pluripotent stem cells encapsulated in 3D microfibrous scaffolds. Biomaterials. 2012;33:9179-9187. [PMID: 22998816 DOI: 10.1016/j.biomaterials.2012.09.006] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
285 Qiu S, Li Y, Imakura Y, Mima S, Hashita T, Iwao T, Matsunaga T. An Efficient Method for the Differentiation of Human iPSC-Derived Endoderm toward Enterocytes and Hepatocytes. Cells 2021;10:812. [PMID: 33917333 DOI: 10.3390/cells10040812] [Reference Citation Analysis]
286 Oh Y, Jang J. Directed Differentiation of Pluripotent Stem Cells by Transcription Factors. Mol Cells. 2019;42:200-209. [PMID: 30884942 DOI: 10.14348/molcells.2019.2439] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
287 Paterson YZ, Cribbs A, Espenel M, Smith EJ, Henson FMD, Guest DJ. Genome-wide transcriptome analysis reveals equine embryonic stem cell-derived tenocytes resemble fetal, not adult tenocytes. Stem Cell Res Ther 2020;11:184. [PMID: 32430075 DOI: 10.1186/s13287-020-01692-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
288 Boroviak T, Nichols J. Primate embryogenesis predicts the hallmarks of human naïve pluripotency. Development 2017;144:175-86. [PMID: 28096211 DOI: 10.1242/dev.145177] [Cited by in Crossref: 72] [Cited by in F6Publishing: 57] [Article Influence: 18.0] [Reference Citation Analysis]
289 Yu L, Li J, Hong J, Takashima Y, Fujimoto N, Nakajima M, Yamamoto A, Dong X, Dang Y, Hou Y, Yang W, Minami I, Okita K, Tanaka M, Luo C, Tang F, Chen Y, Tang C, Kotera H, Liu L. Low Cell-Matrix Adhesion Reveals Two Subtypes of Human Pluripotent Stem Cells. Stem Cell Reports 2018;11:142-56. [PMID: 30008324 DOI: 10.1016/j.stemcr.2018.06.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
290 Braam SR, Denning C, Matsa E, Young LE, Passier R, Mummery CL. Feeder-free culture of human embryonic stem cells in conditioned medium for efficient genetic modification. Nat Protoc 2008;3:1435-43. [PMID: 18772870 DOI: 10.1038/nprot.2008.140] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 4.7] [Reference Citation Analysis]
291 Shiozawa S, Nakajima M, Okahara J, Kuortaki Y, Kisa F, Yoshimatsu S, Nakamura M, Koya I, Yoshimura M, Sasagawa Y, Nikaido I, Sasaki E, Okano H. Primed to Naive-Like Conversion of the Common Marmoset Embryonic Stem Cells. Stem Cells and Development 2020;29:761-73. [DOI: 10.1089/scd.2019.0259] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
292 Ebert AD, Shelley BC, Hurley AM, Onorati M, Castiglioni V, Patitucci TN, Svendsen SP, Mattis VB, McGivern JV, Schwab AJ, Sareen D, Kim HW, Cattaneo E, Svendsen CN. EZ spheres: a stable and expandable culture system for the generation of pre-rosette multipotent stem cells from human ESCs and iPSCs. Stem Cell Res 2013;10:417-27. [PMID: 23474892 DOI: 10.1016/j.scr.2013.01.009] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 9.4] [Reference Citation Analysis]
293 Orlando L, Tanasijevic B, Nakanishi M, Reid JC, García-Rodríguez JL, Chauhan KD, Porras DP, Aslostovar L, Lu JD, Shapovalova Z, Mitchell RR, Boyd AL, Bhatia M. Phosphorylation state of the histone variant H2A.X controls human stem and progenitor cell fate decisions. Cell Rep 2021;34:108818. [PMID: 33691101 DOI: 10.1016/j.celrep.2021.108818] [Reference Citation Analysis]
294 Tsuyama T, Shiraki N, Kume S. Definitive Endoderm Differentiation of Human Embryonic Stem Cells Combined with Selective Elimination of Undifferentiated Cells by Methionine Deprivation. In: Turksen K, editor. Embryonic Stem Cell Protocols. New York: Springer; 2016. pp. 173-80. [DOI: 10.1007/7651_2015_272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
295 Mehta A, Ramachandra CJ, Sequiera GL, Sudibyo Y, Nandihalli M, Yong PJ, Koh CH, Shim W. Phasic modulation of Wnt signaling enhances cardiac differentiation in human pluripotent stem cells by recapitulating developmental ontogeny. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2014;1843:2394-402. [DOI: 10.1016/j.bbamcr.2014.06.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
296 Soto-Gutierrez A, Wertheim JA, Ott HC, Gilbert TW. Perspectives on whole-organ assembly: moving toward transplantation on demand. J Clin Invest 2012;122:3817-23. [PMID: 23114604 DOI: 10.1172/JCI61974] [Cited by in Crossref: 91] [Cited by in F6Publishing: 37] [Article Influence: 10.1] [Reference Citation Analysis]
297 Pringle S, De Bari C, Dell'Accio F, Przyborski S, Cooke MJ, Minger SL, Grigoriadis AE. Mesenchymal differentiation propensity of a human embryonic stem cell line. Cell Prolif 2011;44:120-7. [PMID: 21401753 DOI: 10.1111/j.1365-2184.2011.00744.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
298 Mayhew CN, Wells JM. Converting human pluripotent stem cells into beta-cells: recent advances and future challenges. Curr Opin Organ Transplant. 2010;15:54-60. [PMID: 19855279 DOI: 10.1097/mot.0b013e3283337e1c] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
299 Pekkanen-Mattila M, Kerkelä E, Tanskanen JM, Pietilä M, Pelto-Huikko M, Hyttinen J, Skottman H, Suuronen R, Aalto-Setälä K. Substantial variation in the cardiac differentiation of human embryonic stem cell lines derived and propagated under the same conditions--a comparison of multiple cell lines. Ann Med. 2009;41:360-370. [PMID: 19165643 DOI: 10.1080/07853890802609542] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
300 Lammens T, D'hont I, D'Herde K, Benoit Y, Diez-Fraile A. Long non-coding RNAs in pluripotent stem cell biology. Vet Q 2013;33:202-6. [PMID: 24256470 DOI: 10.1080/01652176.2013.866297] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
301 Rowntree RK, McNeish JD. Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery. Regen Med 2010;5:557-68. [PMID: 20632859 DOI: 10.2217/rme.10.36] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
302 Shiraki N, Shiraki Y, Tsuyama T, Obata F, Miura M, Nagae G, Aburatani H, Kume K, Endo F, Kume S. Methionine metabolism regulates maintenance and differentiation of human pluripotent stem cells. Cell Metab. 2014;19:780-794. [PMID: 24746804 DOI: 10.1016/j.cmet.2014.03.017] [Cited by in Crossref: 274] [Cited by in F6Publishing: 225] [Article Influence: 39.1] [Reference Citation Analysis]
303 Tsugata T, Nikoh N, Kin T, Saitoh I, Noguchi Y, Ueki H, Watanabe M, James Shapiro AM, Noguchi H. Potential Factors for the Differentiation of ESCs/iPSCs Into Insulin-Producing Cells. Cell Med. 2014;7:83-93. [PMID: 26858897 DOI: 10.3727/215517914x685178] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
304 Nishimura K, Ishiwata H, Sakuragi Y, Hayashi Y, Fukuda A, Hisatake K. Live-cell imaging of subcellular structures for quantitative evaluation of pluripotent stem cells. Sci Rep 2019;9:1777. [PMID: 30741960 DOI: 10.1038/s41598-018-37779-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
305 Uosaki H, Fukushima H, Takeuchi A, Matsuoka S, Nakatsuji N, Yamanaka S, Yamashita JK. Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression. PLoS One 2011;6:e23657. [PMID: 21876760 DOI: 10.1371/journal.pone.0023657] [Cited by in Crossref: 219] [Cited by in F6Publishing: 176] [Article Influence: 21.9] [Reference Citation Analysis]
306 Robinton DA, Daley GQ. The promise of induced pluripotent stem cells in research and therapy. Nature. 2012;481:295-305. [PMID: 22258608 DOI: 10.1038/nature10761] [Cited by in Crossref: 768] [Cited by in F6Publishing: 618] [Article Influence: 85.3] [Reference Citation Analysis]
307 Schultz SS, Desbordes SC, Du Z, Kosiyatrakul S, Lipchina I, Studer L, Schildkraut CL. Single-molecule analysis reveals changes in the DNA replication program for the POU5F1 locus upon human embryonic stem cell differentiation. Mol Cell Biol 2010;30:4521-34. [PMID: 20647538 DOI: 10.1128/MCB.00380-10] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
308 Gundry RL, Burridge PW, Boheler KR. Pluripotent stem cell heterogeneity and the evolving role of proteomic technologies in stem cell biology. Proteomics 2011;11:3947-61. [PMID: 21834136 DOI: 10.1002/pmic.201100100] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
309 Fisher OZ, Khademhosseini A, Langer R, Peppas NA. Bioinspired materials for controlling stem cell fate. Acc Chem Res. 2010;43:419-428. [PMID: 20043634 DOI: 10.1021/ar900226q] [Cited by in Crossref: 237] [Cited by in F6Publishing: 193] [Article Influence: 21.5] [Reference Citation Analysis]
310 Nunes SS, Feric N, Pahnke A, Miklas JW, Li M, Coles J, Gagliardi M, Keller G, Radisic M. Human Stem Cell-Derived Cardiac Model of Chronic Drug Exposure. ACS Biomater Sci Eng 2017;3:1911-21. [DOI: 10.1021/acsbiomaterials.5b00496] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
311 Schenke-Layland K, MacLellan WR. Induced pluripotent stem cells: it's like déjà vu all over again. Circulation 2009;120:1462-4. [PMID: 19786628 DOI: 10.1161/CIRCULATIONAHA.109.898544] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
312 Lu J, Baccei A, Lummertz da Rocha E, Guillermier C, McManus S, Finney LA, Zhang C, Steinhauser ML, Li H, Lerou PH. Single-cell RNA sequencing reveals metallothionein heterogeneity during hESC differentiation to definitive endoderm. Stem Cell Res 2018;28:48-55. [PMID: 29427839 DOI: 10.1016/j.scr.2018.01.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
313 Kondo Y, Iwao T, Nakamura K, Sasaki T, Takahashi S, Kamada N, Matsubara T, Gonzalez FJ, Akutsu H, Miyagawa Y, Okita H, Kiyokawa N, Toyoda M, Umezawa A, Nagata K, Matsunaga T, Ohmori S. An efficient method for differentiation of human induced pluripotent stem cells into hepatocyte-like cells retaining drug metabolizing activity. Drug Metab Pharmacokinet. 2014;29:237-243. [PMID: 24334537 DOI: 10.2133/dmpk.dmpk-13-rg-104] [Cited by in Crossref: 39] [Cited by in F6Publishing: 12] [Article Influence: 4.9] [Reference Citation Analysis]
314 Gao Y, Jacot JG. Stem Cells and Progenitor Cells for Tissue-Engineered Solutions to Congenital Heart Defects. Biomark Insights 2015;10:139-46. [PMID: 26379417 DOI: 10.4137/BMI.S20058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
315 Siller R, Naumovska E, Mathapati S, Lycke M, Greenhough S, Sullivan GJ. Development of a rapid screen for the endodermal differentiation potential of human pluripotent stem cell lines. Sci Rep. 2016;6:37178. [PMID: 27872482 DOI: 10.1038/srep37178] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
316 Brennand KJ, Gage FH. Modeling psychiatric disorders through reprogramming. Dis Model Mech 2012;5:26-32. [PMID: 21954066 DOI: 10.1242/dmm.008268] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
317 Lu AQ, Barnstable CJ. Pluripotent Stem Cells as Models of Retina Development. Mol Neurobiol 2019;56:6056-70. [DOI: 10.1007/s12035-019-1504-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
318 Sahu S, Sharan SK. Translating Embryogenesis to Generate Organoids: Novel Approaches to Personalized Medicine. iScience. 2020;23:101485. [PMID: 32864586 DOI: 10.1016/j.isci.2020.101485] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
319 Mfopou JK, Bouwens L. [Differentiation of pluripotent stem cells into pancreatic lineages]. Med Sci (Paris) 2013;29:736-43. [PMID: 24005628 DOI: 10.1051/medsci/2013298012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
320 Marcheque J, Bussolati B, Csete M, Perin L. Concise Reviews: Stem Cells and Kidney Regeneration: An Update. Stem Cells Transl Med 2019;8:82-92. [PMID: 30302937 DOI: 10.1002/sctm.18-0115] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
321 Zimmerlin L, Park TS, Huo JS, Verma K, Pather SR, Talbot CC Jr, Agarwal J, Steppan D, Zhang YW, Considine M, Guo H, Zhong X, Gutierrez C, Cope L, Canto-Soler MV, Friedman AD, Baylin SB, Zambidis ET. Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality. Development 2016;143:4368-80. [PMID: 27660325 DOI: 10.1242/dev.138982] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 9.6] [Reference Citation Analysis]
322 Camnasio S, Delli Carri A, Lombardo A, Grad I, Mariotti C, Castucci A, Rozell B, Lo Riso P, Castiglioni V, Zuccato C, Rochon C, Takashima Y, Diaferia G, Biunno I, Gellera C, Jaconi M, Smith A, Hovatta O, Naldini L, Di Donato S, Feki A, Cattaneo E. The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity. Neurobiol Dis. 2012;46:41-51. [PMID: 22405424 DOI: 10.1016/j.nbd.2011.12.042] [Cited by in Crossref: 118] [Cited by in F6Publishing: 114] [Article Influence: 13.1] [Reference Citation Analysis]
323 Pistollato F, Louisse J, Scelfo B, Mennecozzi M, Accordi B, Basso G, Gaspar JA, Zagoura D, Barilari M, Palosaari T, Sachinidis A, Bremer-Hoffmann S. Development of a pluripotent stem cell derived neuronal model to identify chemically induced pathway perturbations in relation to neurotoxicity: effects of CREB pathway inhibition. Toxicol Appl Pharmacol 2014;280:378-88. [PMID: 25150140 DOI: 10.1016/j.taap.2014.08.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
324 Kuroda T, Yasuda S, Tachi S, Matsuyama S, Kusakawa S, Tano K, Miura T, Matsuyama A, Sato Y. SALL3 expression balance underlies lineage biases in human induced pluripotent stem cell differentiation. Nat Commun. 2019;10:2175. [PMID: 31092818 DOI: 10.1038/s41467-019-09511-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
325 Fischer Y, Ganic E, Ameri J, Xian X, Johannesson M, Semb H. NANOG reporter cell lines generated by gene targeting in human embryonic stem cells. PLoS One. 2010;5. [PMID: 20824089 DOI: 10.1371/journal.pone.0012533] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
326 Koch P, Kokaia Z, Lindvall O, Brüstle O. Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling. Lancet Neurol 2009;8:819-29. [PMID: 19679274 DOI: 10.1016/S1474-4422(09)70202-9] [Cited by in Crossref: 74] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
327 Chen AE, Egli D, Niakan K, Deng J, Akutsu H, Yamaki M, Cowan C, Fitz-Gerald C, Zhang K, Melton DA. Optimal timing of inner cell mass isolation increases the efficiency of human embryonic stem cell derivation and allows generation of sibling cell lines. Cell Stem Cell. 2009;4:103-106. [PMID: 19200798 DOI: 10.1016/j.stem.2008.12.001] [Cited by in Crossref: 140] [Cited by in F6Publishing: 118] [Article Influence: 11.7] [Reference Citation Analysis]
328 Lee SJ, Park C, Lee JY, Kim S, Kwon PJ, Kim W, Jeon YH, Lee E, Yoon YS. Generation of pure lymphatic endothelial cells from human pluripotent stem cells and their therapeutic effects on wound repair. Sci Rep 2015;5:11019. [PMID: 26066093 DOI: 10.1038/srep11019] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 7.7] [Reference Citation Analysis]
329 Mfopou JK, Chen B, Sui L, Sermon K, Bouwens L. Recent advances and prospects in the differentiation of pancreatic cells from human embryonic stem cells. Diabetes 2010;59:2094-101. [PMID: 20805383 DOI: 10.2337/db10-0439] [Cited by in Crossref: 54] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
330 Mehta A, Mathew S, Viswanathan C, Majumdar SA. Intrinsic properties and external factors determine the differentiation bias of human embryonic stem cell lines. Cell Biology International 2010;34:1021-31. [DOI: 10.1042/cbi20100283] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
331 Pellegrini S, Cantarelli E, Sordi V, Nano R, Piemonti L. The state of the art of islet transplantation and cell therapy in type 1 diabetes. Acta Diabetol. 2016;53:683-691. [PMID: 26923700 DOI: 10.1007/s00592-016-0847-z] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 9.2] [Reference Citation Analysis]
332 Zhan M, Riordon DR, Yan B, Tarasova YS, Bruweleit S, Tarasov KV, Li RA, Wersto RP, Boheler KR. The B-MYB transcriptional network guides cell cycle progression and fate decisions to sustain self-renewal and the identity of pluripotent stem cells. PLoS One 2012;7:e42350. [PMID: 22936984 DOI: 10.1371/journal.pone.0042350] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
333 Ai Z, Niu B, Duan K, Si C, Wang S, Xiang L, Zhu X, Zhu Q, Feng C, Yin Y, Zhao S, Kong R, Ji W, Li T. Modulation of Wnt and Activin/Nodal supports efficient derivation, cloning and suspension expansion of human pluripotent stem cells. Biomaterials 2020;249:120015. [PMID: 32311594 DOI: 10.1016/j.biomaterials.2020.120015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
334 Quiskamp N, Bruin JE, Kieffer TJ. Differentiation of human pluripotent stem cells into β-cells: Potential and challenges. Best Pract Res Clin Endocrinol Metab 2015;29:833-47. [PMID: 26696513 DOI: 10.1016/j.beem.2015.10.011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
335 Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, Ambartsumyan G, Aimiuwu O, Richter L, Zhang J. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell. 2009;5:111-123. [PMID: 19570518 DOI: 10.1016/j.stem.2009.06.008] [Cited by in Crossref: 729] [Cited by in F6Publishing: 643] [Article Influence: 60.8] [Reference Citation Analysis]
336 Fernandes AM, Meletti T, Guimarães R, Stelling MP, Marinho PAN, Valladão AS, Rehen SK. Worldwide Survey of Published Procedures to Culture Human Embryonic Stem Cells. Cell Transplant 2010;19:509-23. [DOI: 10.3727/096368909x485067] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
337 Wang L, Serpooshan V, Zhang J. Engineering Human Cardiac Muscle Patch Constructs for Prevention of Post-infarction LV Remodeling. Front Cardiovasc Med 2021;8:621781. [PMID: 33718449 DOI: 10.3389/fcvm.2021.621781] [Reference Citation Analysis]
338 Mehta A, Chung YY, Ng A, Iskandar F, Atan S, Wei H, Dusting G, Sun W, Wong P, Shim W. Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells. Cardiovascular Research 2011;91:577-86. [DOI: 10.1093/cvr/cvr132] [Cited by in Crossref: 77] [Cited by in F6Publishing: 56] [Article Influence: 7.7] [Reference Citation Analysis]
339 Kuroda T, Ando S, Takeno Y, Kishino A, Kimura T. Robust induction of retinal pigment epithelium cells from human induced pluripotent stem cells by inhibiting FGF/MAPK signaling. Stem Cell Research 2019;39:101514. [DOI: 10.1016/j.scr.2019.101514] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
340 Nemati S, Hatami M, Kiani S, Hemmesi K, Gourabi H, Masoudi N, Alaei S, Baharvand H. Long-term self-renewable feeder-free human induced pluripotent stem cell-derived neural progenitors. Stem Cells Dev 2011;20:503-14. [PMID: 20632795 DOI: 10.1089/scd.2010.0143] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
341 Cohen-Carmon D, Meshorer E. Polyglutamine (polyQ) disorders: the chromatin connection. Nucleus 2012;3:433-41. [PMID: 22892726 DOI: 10.4161/nucl.21481] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
342 Yamashita-Sugahara Y, Matsumoto M, Ohtaka M, Nishimura K, Nakanishi M, Mitani K, Okazaki Y. An inhibitor of fibroblast growth factor receptor-1 (FGFR1) promotes late-stage terminal differentiation from NGN3+ pancreatic endocrine progenitors. Sci Rep 2016;6:35908. [PMID: 27786288 DOI: 10.1038/srep35908] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
343 Lin HT, Otsu M, Nakauchi H. Stem cell therapy: an exercise in patience and prudence. Philos Trans R Soc Lond B Biol Sci. 2013;368:20110334. [PMID: 23166396 DOI: 10.1098/rstb.2011.0334] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
344 Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thomson JA, Kamp TJ. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res. 2009;104:e30-e41. [PMID: 19213953 DOI: 10.1161/circresaha.108.192237] [Cited by in Crossref: 882] [Cited by in F6Publishing: 509] [Article Influence: 73.5] [Reference Citation Analysis]
345 Kim H, Lee G, Ganat Y, Papapetrou EP, Lipchina I, Socci ND, Sadelain M, Studer L. miR-371-3 expression predicts neural differentiation propensity in human pluripotent stem cells. Cell Stem Cell 2011;8:695-706. [PMID: 21624813 DOI: 10.1016/j.stem.2011.04.002] [Cited by in Crossref: 102] [Cited by in F6Publishing: 92] [Article Influence: 11.3] [Reference Citation Analysis]
346 Van Hoof D, Liku ME. Directed differentiation of human pluripotent stem cells along the pancreatic endocrine lineage. Methods Mol Biol 2013;997:127-40. [PMID: 23546752 DOI: 10.1007/978-1-62703-348-0_10] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
347 Canham MA, Van Deusen A, Brison DR, De Sousa PA, Downie J, Devito L, Hewitt ZA, Ilic D, Kimber SJ, Moore HD, Murray H, Kunath T. The Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines. Sci Rep 2015;5:17258. [PMID: 26607962 DOI: 10.1038/srep17258] [Cited by in Crossref: 42] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
348 Xu C. Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells. J Mol Cell Cardiol. 2012;52:1203-1212. [PMID: 22484618 DOI: 10.1016/j.yjmcc.2012.03.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
349 Okita K, Nagata N, Yamanaka S. Immunogenicity of Induced Pluripotent Stem Cells. Circ Res 2011;109:720-1. [DOI: 10.1161/res.0b013e318232e187] [Cited by in Crossref: 89] [Cited by in F6Publishing: 39] [Article Influence: 8.9] [Reference Citation Analysis]
350 Lecht S, Gerstenhaber JA, Stabler CT, Pimton P, Karamil S, Marcinkiewicz C, Schulman ES, Lelkes PI. Heterogeneous Mixed-Lineage Differentiation of Mouse Embryonic Stem Cells Induced by Conditioned Media from A549 Cells. Stem Cells and Development 2014;23:1923-36. [DOI: 10.1089/scd.2014.0042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
351 Ortmann D, Vallier L. Variability of human pluripotent stem cell lines. Current Opinion in Genetics & Development 2017;46:179-85. [DOI: 10.1016/j.gde.2017.07.004] [Cited by in Crossref: 63] [Cited by in F6Publishing: 43] [Article Influence: 15.8] [Reference Citation Analysis]
352 Yabe SG, Fukuda S, Takeda F, Nashiro K, Shimoda M, Okochi H. Efficient generation of functional pancreatic β-cells from human induced pluripotent stem cells: 人类诱导性多能干细胞可有效生成有功能的胰腺β细胞. J Diabetes 2017;9:168-79. [DOI: 10.1111/1753-0407.12400] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
353 Manor YS, Massarwa R, Hanna JH. Establishing the human naïve pluripotent state. Curr Opin Genet Dev 2015;34:35-45. [PMID: 26291026 DOI: 10.1016/j.gde.2015.07.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
354 Smith AST, Davis J, Lee G, Mack DL, Kim DH. Muscular dystrophy in a dish: engineered human skeletal muscle mimetics for disease modeling and drug discovery. Drug Discov Today 2016;21:1387-98. [PMID: 27109386 DOI: 10.1016/j.drudis.2016.04.013] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 7.2] [Reference Citation Analysis]
355 Yu H, Cheng L, Cho KS. The potential of stem cell-based therapy for retinal repair. Neural Regen Res 2014;9:1100-3. [PMID: 25206766 DOI: 10.4103/1673-5374.135311] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
356 Freedman BS. Modeling Kidney Disease with iPS Cells. Biomark Insights. 2015;10:153-169. [PMID: 26740740 DOI: 10.4137/bmi.s20054] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
357 Stachelscheid H, Wulf-Goldenberg A, Eckert K, Jensen J, Edsbagge J, Björquist P, Rivero M, Strehl R, Jozefczuk J, Prigione A, Adjaye J, Urbaniak T, Bussmann P, Zeilinger K, Gerlach JC. Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors. J Tissue Eng Regen Med 2013;7:729-41. [PMID: 22438087 DOI: 10.1002/term.1467] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
358 Takahashi K, Yamanaka S. Induced pluripotent stem cells in medicine and biology. Development 2013;140:2457-61. [PMID: 23715538 DOI: 10.1242/dev.092551] [Cited by in Crossref: 155] [Cited by in F6Publishing: 127] [Article Influence: 19.4] [Reference Citation Analysis]
359 Southard SM, Kotipatruni RP, Rust WL. Generation and selection of pluripotent stem cells for robust differentiation to insulin-secreting cells capable of reversing diabetes in rodents. PLoS One 2018;13:e0203126. [PMID: 30183752 DOI: 10.1371/journal.pone.0203126] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
360 Wu SM, Hochedlinger K. Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol. 2011;13:497-505. [PMID: 21540845 DOI: 10.1038/ncb0511-497] [Cited by in Crossref: 372] [Cited by in F6Publishing: 323] [Article Influence: 37.2] [Reference Citation Analysis]
361 Wen Y, Jin S. Production of neural stem cells from human pluripotent stem cells.J Biotechnol. 2014;188:122-129. [PMID: 25150215 DOI: 10.1016/j.jbiotec.2014.07.453] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
362 Samuel R, Daheron L, Liao S, Vardam T, Kamoun WS, Batista A, Buecker C, Schäfer R, Han X, Au P. Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells. Proc Natl Acad Sci USA. 2013;110:12774-12779. [PMID: 23861493 DOI: 10.1073/pnas.1310675110] [Cited by in Crossref: 108] [Cited by in F6Publishing: 96] [Article Influence: 13.5] [Reference Citation Analysis]
363 Ruby KM, Zheng B. Gene targeting in a HUES line of human embryonic stem cells via electroporation. Stem Cells 2009;27:1496-506. [PMID: 19544466 DOI: 10.1002/stem.73] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 5.0] [Reference Citation Analysis]
364 Israel MA, Goldstein LS. Capturing Alzheimer's disease genomes with induced pluripotent stem cells: prospects and challenges. Genome Med 2011;3:49. [PMID: 21867573 DOI: 10.1186/gm265] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
365 Damoiseaux R, Sherman SP, Alva JA, Peterson C, Pyle AD. Integrated chemical genomics reveals modifiers of survival in human embryonic stem cells. Stem Cells 2009;27:533-42. [PMID: 19074420 DOI: 10.1634/stemcells.2008-0596] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
366 Nishino K, Toyoda M, Yamazaki-Inoue M, Fukawatase Y, Chikazawa E, Sakaguchi H, Akutsu H, Umezawa A. DNA methylation dynamics in human induced pluripotent stem cells over time. PLoS Genet. 2011;7:e1002085. [PMID: 21637780 DOI: 10.1371/journal.pgen.1002085] [Cited by in Crossref: 201] [Cited by in F6Publishing: 182] [Article Influence: 20.1] [Reference Citation Analysis]
367 Gage BK, Wideman RD, Kieffer TJ. Generating Pancreatic Endocrine Cells from Pluripotent Stem Cells. In: Islam MS, editor. Islets of Langerhans, 2. ed.. Dordrecht: Springer Netherlands; 2013. pp. 1-37. [DOI: 10.1007/978-94-007-6884-0_49-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
368 Nishino K, Takasawa K, Okamura K, Arai Y, Sekiya A, Akutsu H, Umezawa A. Identification of an epigenetic signature in human induced pluripotent stem cells using a linear machine learning model. Hum Cell 2021;34:99-110. [PMID: 33047283 DOI: 10.1007/s13577-020-00446-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
369 Nishio M, Yoneshiro T, Nakahara M, Suzuki S, Saeki K, Hasegawa M, Kawai Y, Akutsu H, Umezawa A, Yasuda K. Production of functional classical brown adipocytes from human pluripotent stem cells using specific hemopoietin cocktail without gene transfer. Cell Metab. 2012;16:394-406. [PMID: 22958922 DOI: 10.1016/j.cmet.2012.08.001] [Cited by in Crossref: 110] [Cited by in F6Publishing: 92] [Article Influence: 13.8] [Reference Citation Analysis]
370 Yahata N, Boda H, Hata R. Elimination of Mutant mtDNA by an Optimized mpTALEN Restores Differentiation Capacities of Heteroplasmic MELAS-iPSCs. Mol Ther Methods Clin Dev 2021;20:54-68. [PMID: 33376755 DOI: 10.1016/j.omtm.2020.10.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
371 Koh S, Piedrahita JA. From "ES-like" cells to induced pluripotent stem cells: a historical perspective in domestic animals. Theriogenology. 2014;81:103-111. [PMID: 24274415 DOI: 10.1016/j.theriogenology.2013.09.009] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
372 Daneshvar K, Pondick JV, Kim BM, Zhou C, York SR, Macklin JA, Abualteen A, Tan B, Sigova AA, Marcho C, Tremblay KD, Mager J, Choi MY, Mullen AC. DIGIT Is a Conserved Long Noncoding RNA that Regulates GSC Expression to Control Definitive Endoderm Differentiation of Embryonic Stem Cells. Cell Rep 2016;17:353-65. [PMID: 27705785 DOI: 10.1016/j.celrep.2016.09.017] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 8.8] [Reference Citation Analysis]
373 Fong C, Gauthaman K, Bongso A. Teratomas from pluripotent stem cells: A clinical hurdle. J Cell Biochem 2010;111:769-81. [DOI: 10.1002/jcb.22775] [Cited by in Crossref: 144] [Cited by in F6Publishing: 124] [Article Influence: 13.1] [Reference Citation Analysis]
374 Xu XQ, Sun W. Perspective from the heart: the potential of human pluripotent stem cell-derived cardiomyocytes. J Cell Biochem 2013;114:39-46. [PMID: 22903726 DOI: 10.1002/jcb.24359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
375 Tateishi K, He J, Taranova O, Liang G, D'Alessio AC, Zhang Y. Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J Biol Chem. 2008;283:31601-31607. [PMID: 18782754 DOI: 10.1074/jbc.m806597200] [Cited by in Crossref: 252] [Cited by in F6Publishing: 116] [Article Influence: 19.4] [Reference Citation Analysis]
376 Nsair A, MacLellan WR. Induced pluripotent stem cells for regenerative cardiovascular therapies and biomedical discovery. Adv Drug Deliv Rev. 2011;63:324-330. [PMID: 21371511 DOI: 10.1016/j.addr.2011.01.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
377 Wesolowska-Andersen A, Jensen RR, Alcántara MP, Beer NL, Duff C, Nylander V, Gosden M, Witty L, Bowden R, McCarthy MI, Hansson M, Gloyn AL, Honore C. Analysis of Differentiation Protocols Defines a Common Pancreatic Progenitor Molecular Signature and Guides Refinement of Endocrine Differentiation. Stem Cell Reports 2020;14:138-53. [PMID: 31883919 DOI: 10.1016/j.stemcr.2019.11.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
378 Huo JS, Zambidis ET. Pivots of pluripotency: the roles of non-coding RNA in regulating embryonic and induced pluripotent stem cells. Biochim Biophys Acta 2013;1830:2385-94. [PMID: 23104383 DOI: 10.1016/j.bbagen.2012.10.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
379 Strano A, Tuck E, Stubbs VE, Livesey FJ. Variable Outcomes in Neural Differentiation of Human PSCs Arise from Intrinsic Differences in Developmental Signaling Pathways. Cell Rep 2020;31:107732. [PMID: 32521257 DOI: 10.1016/j.celrep.2020.107732] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
380 Jiang W, Zhang D, Bursac N, Zhang Y. WNT3 is a biomarker capable of predicting the definitive endoderm differentiation potential of hESCs. Stem Cell Reports 2013;1:46-52. [PMID: 24052941 DOI: 10.1016/j.stemcr.2013.03.003] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
381 Morris SA, Daley GQ. A blueprint for engineering cell fate: current technologies to reprogram cell identity. Cell Res. 2013;23:33-48. [PMID: 23277278 DOI: 10.1038/cr.2013.1] [Cited by in Crossref: 88] [Cited by in F6Publishing: 77] [Article Influence: 11.0] [Reference Citation Analysis]
382 Cohen DE, Melton D. Turning straw into gold: directing cell fate for regenerative medicine. Nat Rev Genet 2011;12:243-52. [PMID: 21386864 DOI: 10.1038/nrg2938] [Cited by in Crossref: 204] [Cited by in F6Publishing: 149] [Article Influence: 20.4] [Reference Citation Analysis]
383 Chen K, Zheng Y, Xue X, Liu Y, Resto Irizarry AM, Tang H, Fu J. Branching development of early post-implantation human embryonic-like tissues in 3D stem cell culture. Biomaterials 2021;275:120898. [PMID: 34044259 DOI: 10.1016/j.biomaterials.2021.120898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
384 Ilic D, Ogilvie C. Concise Review: Human Embryonic Stem Cells-What Have We Done? What Are We Doing? Where Are We Going?: hESC: Past, Present and Future. Stem Cells 2017;35:17-25. [DOI: 10.1002/stem.2450] [Cited by in Crossref: 75] [Cited by in F6Publishing: 56] [Article Influence: 15.0] [Reference Citation Analysis]
385 Besser RR, Ishahak M, Mayo V, Carbonero D, Claure I, Agarwal A. Engineered Microenvironments for Maturation of Stem Cell Derived Cardiac Myocytes. Theranostics 2018;8:124-40. [PMID: 29290797 DOI: 10.7150/thno.19441] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 14.0] [Reference Citation Analysis]
386 Jung YW, Hysolli E, Kim KY, Tanaka Y, Park IH. Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies. Curr Opin Neurol 2012;25:125-30. [PMID: 22357218 DOI: 10.1097/WCO.0b013e3283518226] [Cited by in Crossref: 45] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
387 Puri MC, Nagy A. Concise Review: Embryonic Stem Cells Versus Induced Pluripotent Stem Cells: The Game Is On. STEM CELLS 2012;30:10-4. [DOI: 10.1002/stem.788] [Cited by in Crossref: 100] [Cited by in F6Publishing: 69] [Article Influence: 10.0] [Reference Citation Analysis]
388 Masia F, Glen A, Stephens P, Langbein W, Borri P. Label-free quantitative chemical imaging and classification analysis of adipogenesis using mouse embryonic stem cells. J Biophotonics 2018;11:e201700219. [DOI: 10.1002/jbio.201700219] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
389 Zhang LF, Ogawa Y, Ahn JY, Namekawa SH, Silva SS, Lee JT. Telomeric RNAs mark sex chromosomes in stem cells. Genetics 2009;182:685-98. [PMID: 19380904 DOI: 10.1534/genetics.109.103093] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
390 Yabe SG, Fukuda S, Nishida J, Takeda F, Nashiro K, Okochi H. Efficient induction of pancreatic alpha cells from human induced pluripotent stem cells by controlling the timing for BMP antagonism and activation of retinoic acid signaling. PLoS One 2021;16:e0245204. [PMID: 33428669 DOI: 10.1371/journal.pone.0245204] [Reference Citation Analysis]
391 Seiler A, Oelgeschläger M, Liebsch M, Pirow R, Riebeling C, Tralau T, Luch A. Developmental toxicity testing in the 21st century: the sword of Damocles shattered by embryonic stem cell assays? Arch Toxicol 2011;85:1361-72. [DOI: 10.1007/s00204-011-0767-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
392 De Paepe C, Krivega M, Cauffman G, Geens M, Van de Velde H. Totipotency and lineage segregation in the human embryo. MHR: Basic science of reproductive medicine 2014;20:599-618. [DOI: 10.1093/molehr/gau027] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
393 Abou-Saleh H, Zouein FA, El-Yazbi A, Sanoudou D, Raynaud C, Rao C, Pintus G, Dehaini H, Eid AH. The march of pluripotent stem cells in cardiovascular regenerative medicine. Stem Cell Res Ther 2018;9:201. [PMID: 30053890 DOI: 10.1186/s13287-018-0947-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
394 Ramachandra CJ, Mehta A, Lua CH, Chitre A, Ja KP, Shim W. ErbB Receptor Tyrosine Kinase: A Molecular Switch Between Cardiac and Neuroectoderm Specification in Human Pluripotent Stem Cells. Stem Cells 2016;34:2461-70. [PMID: 27324647 DOI: 10.1002/stem.2420] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
395 Parrotta EI, Lucchino V, Scaramuzzino L, Scalise S, Cuda G. Modeling Cardiac Disease Mechanisms Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Progress, Promises and Challenges. Int J Mol Sci 2020;21:E4354. [PMID: 32575374 DOI: 10.3390/ijms21124354] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
396 Zhu Z, Huangfu D. Human pluripotent stem cells: an emerging model in developmental biology. Development 2013;140:705-17. [PMID: 23362344 DOI: 10.1242/dev.086165] [Cited by in Crossref: 104] [Cited by in F6Publishing: 89] [Article Influence: 13.0] [Reference Citation Analysis]
397 Jiang Y, Zhang MJ, Hu BY. Specification of functional neurons and glia from human pluripotent stem cells. Protein Cell 2012;3:818-25. [PMID: 23143871 DOI: 10.1007/s13238-012-2086-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
398 Finklea FB, Tian Y, Kerscher P, Seeto WJ, Ellis ME, Lipke EA. Engineered cardiac tissue microsphere production through direct differentiation of hydrogel-encapsulated human pluripotent stem cells. Biomaterials 2021;274:120818. [PMID: 34023620 DOI: 10.1016/j.biomaterials.2021.120818] [Reference Citation Analysis]
399 Omole AE, Fakoya AOJ. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications. PeerJ 2018;6:e4370. [PMID: 29770269 DOI: 10.7717/peerj.4370] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 15.7] [Reference Citation Analysis]
400 Pellegrini S, Manenti F, Chimienti R, Nano R, Ottoboni L, Ruffini F, Martino G, Ravassard P, Piemonti L, Sordi V. Differentiation of Sendai Virus-Reprogrammed iPSC into β Cells, Compared with Human Pancreatic Islets and Immortalized β Cell Line. Cell Transplant 2018;27:1548-60. [PMID: 30251567 DOI: 10.1177/0963689718798564] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
401 Vilchez D, Boyer L, Morantte I, Lutz M, Merkwirth C, Joyce D, Spencer B, Page L, Masliah E, Berggren WT, Gage FH, Dillin A. Increased proteasome activity in human embryonic stem cells is regulated by PSMD11. Nature 2012;489:304-8. [PMID: 22972301 DOI: 10.1038/nature11468] [Cited by in Crossref: 263] [Cited by in F6Publishing: 227] [Article Influence: 29.2] [Reference Citation Analysis]
402 Borowiak M, Maehr R, Chen S, Chen AE, Tang W, Fox JL, Schreiber SL, Melton DA. Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells. Cell Stem Cell. 2009;4:348-358. [PMID: 19341624 DOI: 10.1016/j.stem.2009.01.014] [Cited by in Crossref: 318] [Cited by in F6Publishing: 275] [Article Influence: 26.5] [Reference Citation Analysis]
403 Kyttälä A, Moraghebi R, Valensisi C, Kettunen J, Andrus C, Pasumarthy KK, Nakanishi M, Nishimura K, Ohtaka M, Weltner J, Van Handel B, Parkkonen O, Sinisalo J, Jalanko A, Hawkins RD, Woods NB, Otonkoski T, Trokovic R. Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential. Stem Cell Reports. 2016;6:200-212. [PMID: 26777058 DOI: 10.1016/j.stemcr.2015.12.009] [Cited by in Crossref: 130] [Cited by in F6Publishing: 104] [Article Influence: 26.0] [Reference Citation Analysis]
404 Hazeltine LB, Selekman JA, Palecek SP. Engineering the human pluripotent stem cell microenvironment to direct cell fate. Biotechnol Adv 2013;31:1002-19. [PMID: 23510904 DOI: 10.1016/j.biotechadv.2013.03.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
405 Giulitti S, Pellegrini M, Zorzan I, Martini P, Gagliano O, Mutarelli M, Ziller MJ, Cacchiarelli D, Romualdi C, Elvassore N, Martello G. Direct generation of human naive induced pluripotent stem cells from somatic cells in microfluidics. Nat Cell Biol 2019;21:275-86. [DOI: 10.1038/s41556-018-0254-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
406 Becherucci F, Mazzinghi B, Allinovi M, Angelotti ML, Romagnani P. Regenerating the kidney using human pluripotent stem cells and renal progenitors. Expert Opin Biol Ther 2018;18:795-806. [PMID: 29939787 DOI: 10.1080/14712598.2018.1492546] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
407 Niwa A, Heike T, Umeda K, Oshima K, Kato I, Sakai H, Suemori H, Nakahata T, Saito MK. A novel serum-free monolayer culture for orderly hematopoietic differentiation of human pluripotent cells via mesodermal progenitors. PLoS One 2011;6:e22261. [PMID: 21818303 DOI: 10.1371/journal.pone.0022261] [Cited by in Crossref: 73] [Cited by in F6Publishing: 58] [Article Influence: 7.3] [Reference Citation Analysis]
408 Chmielowiec J, Borowiak M. In vitro differentiation and expansion of human pluripotent stem cell-derived pancreatic progenitors. Rev Diabet Stud 2014;11:19-34. [PMID: 25148365 DOI: 10.1900/RDS.2014.11.19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
409 Mack DL, Guan X, Wagoner A, Walker SJ, Childers MK. Disease-in-a-dish: the contribution of patient-specific induced pluripotent stem cell technology to regenerative rehabilitation. Am J Phys Med Rehabil 2014;93:S155-68. [PMID: 25122102 DOI: 10.1097/PHM.0000000000000141] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
410 Preynat-seauve O, Suter DM, Tirefort D, Turchi L, Virolle T, Chneiweiss H, Foti M, Lobrinus J, Stoppini L, Feki A, Dubois-dauphin M, Krause KH. Development of human nervous tissue upon differentiation of embryonic stem cells in three-dimensional culture. Stem Cells 2009;27:509-20. [DOI: 10.1002/stem.20080600] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
411 Mummery CL, Zhang J, Ng ES, Elliott DA, Elefanty AG, Kamp TJ. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res. 2012;111:344-358. [PMID: 22821908 DOI: 10.1161/CIRCRESAHA.110.227512] [Cited by in Crossref: 438] [Cited by in F6Publishing: 236] [Article Influence: 48.7] [Reference Citation Analysis]
412 Tran R, Moraes C, Hoesli CA. Developmentally-Inspired Biomimetic Culture Models to Produce Functional Islet-Like Cells From Pluripotent Precursors. Front Bioeng Biotechnol 2020;8:583970. [PMID: 33117786 DOI: 10.3389/fbioe.2020.583970] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
413 Niakan KK, Han J, Pedersen RA, Simon C, Pera RA. Human pre-implantation embryo development. Development. 2012;139:829-841. [PMID: 22318624 DOI: 10.1242/dev.060426] [Cited by in Crossref: 187] [Cited by in F6Publishing: 159] [Article Influence: 20.8] [Reference Citation Analysis]
414 Geater C, Hernandez S, Thompson L, Mattis VB. Cellular Models: HD Patient-Derived Pluripotent Stem Cells. Methods Mol Biol 2018;1780:41-73. [PMID: 29856014 DOI: 10.1007/978-1-4939-7825-0_4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
415 Mai HN, Kim EJ, Jung HS. Application of hiPSCs in tooth regeneration via cellular modulation. J Oral Biosci 2021:S1349-0079(21)00057-8. [PMID: 34033906 DOI: 10.1016/j.job.2021.05.002] [Reference Citation Analysis]
416 Buecker C, Geijsen N. Different Flavors of Pluripotency, Molecular Mechanisms, and Practical Implications. Cell Stem Cell 2010;7:559-64. [DOI: 10.1016/j.stem.2010.10.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
417 Marchetto MC, Winner B, Gage FH. Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases. Hum Mol Genet 2010;19:R71-6. [PMID: 20418487 DOI: 10.1093/hmg/ddq159] [Cited by in Crossref: 108] [Cited by in F6Publishing: 91] [Article Influence: 9.8] [Reference Citation Analysis]
418 Zhu Z, Li QV, Lee K, Rosen BP, González F, Soh CL, Huangfu D. Genome Editing of Lineage Determinants in Human Pluripotent Stem Cells Reveals Mechanisms of Pancreatic Development and Diabetes. Cell Stem Cell 2016;18:755-68. [PMID: 27133796 DOI: 10.1016/j.stem.2016.03.015] [Cited by in Crossref: 88] [Cited by in F6Publishing: 75] [Article Influence: 17.6] [Reference Citation Analysis]
419 Amabile G, Meissner A. Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol Med 2009;15:59-68. [PMID: 19162546 DOI: 10.1016/j.molmed.2008.12.003] [Cited by in Crossref: 247] [Cited by in F6Publishing: 205] [Article Influence: 20.6] [Reference Citation Analysis]
420 Naujok O, Diekmann U, Lenzen S. The generation of definitive endoderm from human embryonic stem cells is initially independent from activin A but requires canonical Wnt-signaling. Stem Cell Rev Rep 2014;10:480-93. [PMID: 24913278 DOI: 10.1007/s12015-014-9509-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
421 Takahashi K, Narita M, Yokura M, Ichisaka T, Yamanaka S. Human induced pluripotent stem cells on autologous feeders. PLoS One. 2009;4:e8067. [PMID: 19956543 DOI: 10.1371/journal.pone.0008067] [Cited by in Crossref: 73] [Cited by in F6Publishing: 61] [Article Influence: 6.1] [Reference Citation Analysis]
422 Keller A, Dziedzicka D, Zambelli F, Markouli C, Sermon K, Spits C, Geens M. Genetic and epigenetic factors which modulate differentiation propensity in human pluripotent stem cells. Hum Reprod Update 2018;24:162-75. [PMID: 29377992 DOI: 10.1093/humupd/dmx042] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
423 Brock A, Goh HT, Yang B, Lu Y, Li H, Loh YH. Cellular reprogramming: a new technology frontier in pharmaceutical research. Pharm Res 2012;29:35-52. [PMID: 22068279 DOI: 10.1007/s11095-011-0618-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
424 Goldman B. Embryonic Stem Cells 2.0. Nat Rep Stem Cells. [DOI: 10.1038/stemcells.2008.67] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
425 Kim D, Lee JS, Leem JW, Huh YJ, Kim JY, Kim H, Park I, Daley GQ, Hwang D, Kim D. Robust Enhancement of Neural Differentiation from Human ES and iPS Cells Regardless of their Innate Difference in Differentiation Propensity. Stem Cell Rev and Rep 2010;6:270-81. [DOI: 10.1007/s12015-010-9138-1] [Cited by in Crossref: 153] [Cited by in F6Publishing: 144] [Article Influence: 13.9] [Reference Citation Analysis]
426 Székely T Jr, Burrage K, Mangel M, Bonsall MB. Stochastic dynamics of interacting haematopoietic stem cell niche lineages. PLoS Comput Biol 2014;10:e1003794. [PMID: 25188267 DOI: 10.1371/journal.pcbi.1003794] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
427 Zhu FF, Zhang PB, Zhang DH, Sui X, Yin M, Xiang TT, Shi Y, Ding MX, Deng H. Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells. Diabetologia. 2011;54:2325-2336. [PMID: 21755313 DOI: 10.1007/s00125-011-2246-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
428 Avior Y, Biancotti JC, Benvenisty N. TeratoScore: Assessing the Differentiation Potential of Human Pluripotent Stem Cells by Quantitative Expression Analysis of Teratomas. Stem Cell Reports. 2015;4:967-974. [PMID: 26070610 DOI: 10.1016/j.stemcr.2015.05.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
429 Sommer CA, Mostoslavsky G. The evolving field of induced pluripotency: recent progress and future challenges. J Cell Physiol 2013;228:267-75. [PMID: 22767332 DOI: 10.1002/jcp.24155] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
430 Palakkan AA, Nanda J, Ross JA. Pluripotent stem cells to hepatocytes, the journey so far. Biomed Rep 2017;6:367-73. [PMID: 28413633 DOI: 10.3892/br.2017.867] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
431 Zhang Y, Liao S, Yang M, Liang X, Poon MW, Wong CY, Wang J, Zhou Z, Cheong SK, Lee CN, Tse HF, Lian Q. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension. Cell Transplant 2012;21:2225-39. [PMID: 22776744 DOI: 10.3727/096368912X653020] [Cited by in Crossref: 49] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
432 Jamal M, Lewandowski SL, Lawton ML, Huang GT, Ikonomou L. Derivation and characterization of putative craniofacial mesenchymal progenitor cells from human induced pluripotent stem cells. Stem Cell Res 2018;33:100-9. [PMID: 30340089 DOI: 10.1016/j.scr.2018.10.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
433 Mandenius C, Andersson TB, Alves PM, Batzl-hartmann C, Björquist P, Carrondo MJ, Chesne C, Coecke S, Edsbagge J, Fredriksson JM, Gerlach JC, Heinzle E, Ingelman-sundberg M, Johansson I, Küppers-munther B, Müller-vieira U, Noor F, Zeilinger K. Toward Preclinical Predictive Drug Testing for Metabolism and Hepatotoxicity by Using In Vitro Models Derived from Human Embryonic Stem Cells and Human Cell Lines — A Report on the Vitrocellomics EU-project. Altern Lab Anim 2011;39:147-71. [DOI: 10.1177/026119291103900210] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
434 Gaspard N, Vanderhaeghen P. From stem cells to neural networks: recent advances and perspectives for neurodevelopmental disorders. Dev Med Child Neurol 2011;53:13-7. [PMID: 21087236 DOI: 10.1111/j.1469-8749.2010.03827.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
435 Qiu Z, Mishra A, Li M, Farnsworth SL, Guerra B, Lanford RE, Hornsby PJ. Marmoset induced pluripotent stem cells: Robust neural differentiation following pretreatment with dimethyl sulfoxide. Stem Cell Res 2015;15:141-50. [PMID: 26070112 DOI: 10.1016/j.scr.2015.05.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
436 Hanna JH, Saha K, Jaenisch R. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 2010;143:508-25. [PMID: 21074044 DOI: 10.1016/j.cell.2010.10.008] [Cited by in Crossref: 510] [Cited by in F6Publishing: 423] [Article Influence: 46.4] [Reference Citation Analysis]
437 Gupta SK, Wesolowska-Andersen A, Ringgaard AK, Jaiswal H, Song L, Hastoy B, Ingvorsen C, Taheri-Ghahfarokhi A, Magnusson B, Maresca M, Jensen RR, Beer NL, Fels JJ, Grunnet LG, Thomas MK, Gloyn AL, Hicks R, McCarthy MI, Hansson M, Honoré C. NKX6.1 induced pluripotent stem cell reporter lines for isolation and analysis of functionally relevant neuronal and pancreas populations. Stem Cell Res 2018;29:220-31. [PMID: 29734117 DOI: 10.1016/j.scr.2018.04.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
438 Chien KR. Regenerative medicine and human models of human disease. Nature 2008;453:302-5. [DOI: 10.1038/nature07037] [Cited by in Crossref: 68] [Cited by in F6Publishing: 53] [Article Influence: 5.2] [Reference Citation Analysis]
439 Csete M. Translational prospects for human induced pluripotent stem cells. Regen Med 2010;5:509-19. [PMID: 20632855 DOI: 10.2217/rme.10.39] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
440 Kramer N, Rosner M, Kovacic B, Hengstschläger M. Full biological characterization of human pluripotent stem cells will open the door to translational research. Arch Toxicol 2016;90:2173-86. [PMID: 27325309 DOI: 10.1007/s00204-016-1763-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
441 Kim JM, Moon SH, Lee SG, Cho YJ, Hong KS, Lee JH, Lee HJ, Chung HM. Assessment of differentiation aspects by the morphological classification of embryoid bodies derived from human embryonic stem cells. Stem Cells Dev. 2011;20:1925-1935. [PMID: 21388292 DOI: 10.1089/scd.2010.0476] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
442 Lin SC, Loza A, Antrim L, Talbot P. Video bioinformatics analysis of human pluripotent stem cell morphology, quality, and cellular dynamics. Stem Cells Transl Med 2021;10:1343-59. [PMID: 34089307 DOI: 10.1002/sctm.15-0352] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
443 Inoue H, Yamanaka S. The use of induced pluripotent stem cells in drug development. Clin Pharmacol Ther. 2011;89:655-661. [PMID: 21430656 DOI: 10.1038/clpt.2011.38] [Cited by in Crossref: 164] [Cited by in F6Publishing: 131] [Article Influence: 16.4] [Reference Citation Analysis]
444 Han W, Zhao Y, Fu X. Induced Pluripotent Stem Cells: The Dragon Awakens. BioScience 2010;60:278-85. [DOI: 10.1525/bio.2010.60.4.6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
445 Salewski RP, Buttigieg J, Mitchell RA, van der Kooy D, Nagy A, Fehlings MG. The generation of definitive neural stem cells from PiggyBac transposon-induced pluripotent stem cells can be enhanced by induction of the NOTCH signaling pathway. Stem Cells Dev. 2013;22:383-396. [PMID: 22889305 DOI: 10.1089/scd.2012.0218] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
446 Jacobson EF, Chen Z, Stoukides DM, Nair GG, Hebrok M, Tzanakakis ES. Non-xenogeneic expansion and definitive endoderm differentiation of human pluripotent stem cells in an automated bioreactor. Biotechnol Bioeng 2021;118:979-91. [PMID: 33205831 DOI: 10.1002/bit.27629] [Reference Citation Analysis]
447 Hung SSC, Khan S, Lo CY, Hewitt AW, Wong RCB. Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases. Pharmacol Ther. 2017;177:32-43. [PMID: 28223228 DOI: 10.1016/j.pharmthera.2017.02.026] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
448 Kamm RD, Bashir R, Arora N, Dar RD, Gillette MU, Griffith LG, Kemp ML, Kinlaw K, Levin M, Martin AC, McDevitt TC, Nerem RM, Powers MJ, Saif TA, Sharpe J, Takayama S, Takeuchi S, Weiss R, Ye K, Yevick HG, Zaman MH. Perspective: The promise of multi-cellular engineered living systems. APL Bioeng 2018;2:040901. [PMID: 31069321 DOI: 10.1063/1.5038337] [Cited by in Crossref: 59] [Cited by in F6Publishing: 37] [Article Influence: 19.7] [Reference Citation Analysis]
449 Lau F, Ahfeldt T, Osafune K, Akustsu H, Cowan CA. Induced pluripotent stem (iPS) cells: an up-to-the-minute review. F1000 Biol Rep 2009;1:84. [PMID: 20948605 DOI: 10.3410/B1-84] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
450 Skibinski G, Finkbeiner S. Drug discovery in Parkinson's disease-Update and developments in the use of cellular models. Int J High Throughput Screen 2011;2011:15-25. [PMID: 23505333 DOI: 10.2147/IJHTS.S8681] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
451 Tulpule A, Kelley JM, Lensch MW, McPherson J, Park IH, Hartung O, Nakamura T, Schlaeger TM, Shimamura A, Daley GQ. Pluripotent stem cell models of Shwachman-Diamond syndrome reveal a common mechanism for pancreatic and hematopoietic dysfunction. Cell Stem Cell 2013;12:727-36. [PMID: 23602541 DOI: 10.1016/j.stem.2013.04.002] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
452 Honsho K, Hirose M, Hatori M, Yasmin L, Izu H, Matoba S, Togayachi S, Miyoshi H, Sankai T, Ogura A, Honda A. Naïve-like conversion enhances the difference in innate in vitro differentiation capacity between rabbit ES cells and iPS cells. J Reprod Dev 2015;61:13-9. [PMID: 25345855 DOI: 10.1262/jrd.2014-098] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
453 Synnergren J, Heins N, Brolén G, Eriksson G, Lindahl A, Hyllner J, Olsson B, Sartipy P, Björquist P. Transcriptional profiling of human embryonic stem cells differentiating to definitive and primitive endoderm and further toward the hepatic lineage. Stem Cells Dev 2010;19:961-78. [PMID: 19757991 DOI: 10.1089/scd.2009.0220] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
454 Colleoni S, Galli C, Gaspar JA, Meganathan K, Jagtap S, Hescheler J, Zagoura D, Bremer S, Sachinidis A, Lazzari G. A comparative transcriptomic study on the effects of valproic acid on two different hESCs lines in a neural teratogenicity test system. Toxicology Letters 2014;231:38-44. [DOI: 10.1016/j.toxlet.2014.08.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
455 Tudurí E, Bruin JE, Kieffer TJ. Restoring insulin production for type 1 diabetes. J Diabetes. 2012;4:319-331. [PMID: 22429761 DOI: 10.1111/j.1753-0407.2012.00196.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
456 Holditch SJ, Terzic A, Ikeda Y. Concise review: pluripotent stem cell-based regenerative applications for failing β-cell function. Stem Cells Transl Med. 2014;3:653-661. [PMID: 24646490 DOI: 10.5966/sctm.2013-0184] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
457 Nishio M, Saeki K. Differentiation of human pluripotent stem cells into highly functional classical brown adipocytes. Methods Enzymol. 2014;537:177-197. [PMID: 24480347 DOI: 10.1016/b978-0-12-411619-1.00010-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
458 Nomura Y, Ishikawa M, Yashiro Y, Sanggarnjanavanich S, Yamaguchi T, Arai C, Noda K, Takano Y, Nakamura Y, Hanada N. Human periodontal ligament fibroblasts are the optimal cell source for induced pluripotent stem cells. Histochem Cell Biol 2012;137:719-32. [DOI: 10.1007/s00418-012-0923-6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
459 Van Hoof D, D'amour KA, German MS. Derivation of insulin-producing cells from human embryonic stem cells. Stem Cell Research 2009;3:73-87. [DOI: 10.1016/j.scr.2009.08.003] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 6.7] [Reference Citation Analysis]
460 Goyal S, Kim S, Chen IS, Chou T. Mechanisms of blood homeostasis: lineage tracking and a neutral model of cell populations in rhesus macaques. BMC Biol 2015;13:85. [PMID: 26486451 DOI: 10.1186/s12915-015-0191-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
461 Gallegos-cárdenas A, Webb R, Jordan E, West R, West FD, Yang J, Wang K, Stice SL. Pig Induced Pluripotent Stem Cell-Derived Neural Rosettes Developmentally Mimic Human Pluripotent Stem Cell Neural Differentiation. Stem Cells and Development 2015;24:1901-11. [DOI: 10.1089/scd.2015.0025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
462 Lehnen D, Barral S, Cardoso T, Grealish S, Heuer A, Smiyakin A, Kirkeby A, Kollet J, Cremer H, Parmar M, Bosio A, Knöbel S. IAP-Based Cell Sorting Results in Homogeneous Transplantable Dopaminergic Precursor Cells Derived from Human Pluripotent Stem Cells. Stem Cell Reports 2017;9:1207-20. [PMID: 28943253 DOI: 10.1016/j.stemcr.2017.08.016] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
463 Sohn YD, Han JW, Yoon YS. Generation of induced pluripotent stem cells from somatic cells. Prog Mol Biol Transl Sci. 2012;111:1-26. [PMID: 22917224 DOI: 10.1016/b978-0-12-398459-3.00001-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
464 Fukusumi H, Shofuda T, Bamba Y, Yamamoto A, Kanematsu D, Handa Y, Okita K, Nakamura M, Yamanaka S, Okano H, Kanemura Y. Establishment of Human Neural Progenitor Cells from Human Induced Pluripotent Stem Cells with Diverse Tissue Origins. Stem Cells Int 2016;2016:7235757. [PMID: 27212953 DOI: 10.1155/2016/7235757] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
465 Van der Jeught M, O'Leary T, Duggal G, De Sutter P, Chuva de Sousa Lopes S, Heindryckx B. The post-inner cell mass intermediate: implications for stem cell biology and assisted reproductive technology. Hum Reprod Update 2015;21:616-26. [PMID: 26089403 DOI: 10.1093/humupd/dmv028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
466 O'Keefe CM, Pisanic TR 2nd, Zec H, Overman MJ, Herman JG, Wang TH. Facile profiling of molecular heterogeneity by microfluidic digital melt. Sci Adv 2018;4:eaat6459. [PMID: 30263958 DOI: 10.1126/sciadv.aat6459] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
467 Ahmad R, Wolber W, Eckardt S, Koch P, Schmitt J, Semechkin R, Geis C, Heckmann M, Brüstle O, McLaughlin JK. Functional neuronal cells generated by human parthenogenetic stem cells. PLoS One. 2012;7:e42800. [PMID: 22880113 DOI: 10.1371/journal.pone.0042800] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
468 Martinez-Fernandez A, Li X, Hartjes KA, Terzic A, Nelson TJ. Natural cardiogenesis-based template predicts cardiogenic potential of induced pluripotent stem cell lines. Circ Cardiovasc Genet 2013;6:462-71. [PMID: 24036272 DOI: 10.1161/CIRCGENETICS.113.000045] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
469 Smith LA, Hidalgo Aguilar A, Owens DDG, Quelch RH, Knight E, Przyborski SA. Using Advanced Cell Culture Techniques to Differentiate Pluripotent Stem Cells and Recreate Tissue Structures Representative of Teratoma Xenografts. Front Cell Dev Biol 2021;9:667246. [PMID: 34026759 DOI: 10.3389/fcell.2021.667246] [Reference Citation Analysis]
470 Rhee YH, Ko JY, Chang MY, Yi SH, Kim D, Kim CH, Shim JW, Jo AY, Kim BW, Lee H, Lee SH, Suh W, Park CH, Koh HC, Lee YS, Lanza R, Kim KS, Lee SH. Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. J Clin Invest 2011;121:2326-35. [PMID: 21576821 DOI: 10.1172/JCI45794] [Cited by in Crossref: 166] [Cited by in F6Publishing: 94] [Article Influence: 16.6] [Reference Citation Analysis]
471 Al Tanoury Z, Zimmerman JF, Rao J, Sieiro D, McNamara HM, Cherrier T, Rodríguez-delaRosa A, Hick-Colin A, Bousson F, Fugier-Schmucker C, Marchiano F, Habermann B, Chal J, Nesmith AP, Gapon S, Wagner E, Gupta VA, Bassel-Duby R, Olson EN, Cohen AE, Parker KK, Pourquié O. Prednisolone rescues Duchenne muscular dystrophy phenotypes in human pluripotent stem cell-derived skeletal muscle in vitro. Proc Natl Acad Sci U S A 2021;118:e2022960118. [PMID: 34260377 DOI: 10.1073/pnas.2022960118] [Reference Citation Analysis]
472 Tzur G, Levy A, Meiri E, Barad O, Spector Y, Bentwich Z, Mizrahi L, Katzenellenbogen M, Ben-Shushan E, Reubinoff BE. MicroRNA expression patterns and function in endodermal differentiation of human embryonic stem cells. PLoS One. 2008;3:e3726. [PMID: 19015728 DOI: 10.1371/journal.pone.0003726] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 5.8] [Reference Citation Analysis]
473 Kusumoto D, Lachmann M, Kunihiro T, Yuasa S, Kishino Y, Kimura M, Katsuki T, Itoh S, Seki T, Fukuda K. Automated Deep Learning-Based System to Identify Endothelial Cells Derived from Induced Pluripotent Stem Cells. Stem Cell Reports. 2018;10:1687-1695. [PMID: 29754958 DOI: 10.1016/j.stemcr.2018.04.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
474 Gupta MK, Illich DJ, Gaarz A, Matzkies M, Nguemo F, Pfannkuche K, Liang H, Classen S, Reppel M, Schultze JL, Hescheler J, Sarić T. Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar. BMC Dev Biol 2010;10:98. [PMID: 20843318 DOI: 10.1186/1471-213X-10-98] [Cited by in Crossref: 57] [Cited by in F6Publishing: 40] [Article Influence: 5.2] [Reference Citation Analysis]
475 Seifinejad A, Tabebordbar M, Baharvand H, Boyer LA, Hosseini Salekdeh G. Progress and Promise Towards Safe Induced Pluripotent Stem Cells for Therapy. Stem Cell Rev and Rep 2010;6:297-306. [DOI: 10.1007/s12015-010-9121-x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
476 Hu BY, Weick JP, Yu J, Ma LX, Zhang XQ, Thomson JA, Zhang SC. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA. 2010;107:4335-4340. [PMID: 20160098 DOI: 10.1073/pnas.0910012107] [Cited by in Crossref: 731] [Cited by in F6Publishing: 636] [Article Influence: 66.5] [Reference Citation Analysis]
477 Wen Y, Chen B, Ildstad ST. Stem cell-based strategies for the treatment of type 1 diabetes mellitus. Expert Opin Biol Ther 2011;11:41-53. [PMID: 21110785 DOI: 10.1517/14712598.2011.540235] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
478 Hu BY, Weick JP, Yu J, Ma LX, Zhang XQ, Thomson JA, Zhang SC. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA. 2010;107:4335-4340. [PMID: 20160098 DOI: 10.1073/pnas.01910012107] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
479 Mostajo-Radji MA, Schmitz MT, Montoya ST, Pollen AA. Reverse engineering human brain evolution using organoid models. Brain Res 2020;1729:146582. [PMID: 31809699 DOI: 10.1016/j.brainres.2019.146582] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
480 Ye J, Bates N, Soteriou D, Grady L, Edmond C, Ross A, Kerby A, Lewis PA, Adeniyi T, Wright R, Poulton KV, Lowe M, Kimber SJ, Brison DR. High quality clinical grade human embryonic stem cell lines derived from fresh discarded embryos. Stem Cell Res Ther 2017;8:128. [PMID: 28583200 DOI: 10.1186/s13287-017-0561-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
481 Hiratsuka K, Monkawa T, Akiyama T, Nakatake Y, Oda M, Goparaju SK, Kimura H, Chikazawa-Nohtomi N, Sato S, Ishiguro K, Yamaguchi S, Suzuki S, Morizane R, Ko SBH, Itoh H, Ko MSH. Induction of human pluripotent stem cells into kidney tissues by synthetic mRNAs encoding transcription factors. Sci Rep 2019;9:913. [PMID: 30696889 DOI: 10.1038/s41598-018-37485-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
482 Coulombel L, la relecture critique A, John De Vos et Michel Pucéat D. FISH-ESC: Premier colloque international sur la recherche dédiée aux cellules souches embryonnaires humaines. Med Sci (Paris) 2008;24:419-26. [DOI: 10.1051/medsci/2008244419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
483 Hosoya M. Preparation of pancreatic β-cells from human iPS cells with small molecules. Islets 2012;4:249-52. [PMID: 22722666 DOI: 10.4161/isl.20856] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
484 Prowse AB, Timmins NE, Yau TM, Li R, Weisel RD, Keller G, Zandstra PW. Transforming the Promise of Pluripotent Stem Cell-Derived Cardiomyocytes to a Therapy: Challenges and Solutions for Clinical Trials. Canadian Journal of Cardiology 2014;30:1335-49. [DOI: 10.1016/j.cjca.2014.08.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
485 de Peppo GM, Marolt D. Make no bones about it: cells could soon be reprogrammed to grow replacement bones? Expert Opin Biol Ther 2014;14:1-5. [PMID: 24053578 DOI: 10.1517/14712598.2013.840581] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
486 Naujok O, Lenzen S. A critical re-evaluation of CD24-positivity of human embryonic stem cells differentiated into pancreatic progenitors. Stem Cell Rev. 2012;8:779-791. [PMID: 22529013 DOI: 10.1007/s12015-012-9362-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
487 Cheung AY, Horvath LM, Carrel L, Ellis J. X-chromosome inactivation in rett syndrome human induced pluripotent stem cells. Front Psychiatry 2012;3:24. [PMID: 22470355 DOI: 10.3389/fpsyt.2012.00024] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
488 Spyrou J, Gardner DK, Harvey AJ. Metabolism Is a Key Regulator of Induced Pluripotent Stem Cell Reprogramming.Stem Cells Int. 2019;2019:7360121. [PMID: 31191682 DOI: 10.1155/2019/7360121] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
489 Major T, Menon J, Auyeung G, Soldner F, Hockemeyer D, Jaenisch R, Tabar V. Transgene excision has no impact on in vivo integration of human iPS derived neural precursors. PLoS One 2011;6:e24687. [PMID: 21961042 DOI: 10.1371/journal.pone.0024687] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
490 Lippmann ES, Estevez-Silva MC, Ashton RS. Defined human pluripotent stem cell culture enables highly efficient neuroepithelium derivation without small molecule inhibitors. Stem Cells 2014;32:1032-42. [PMID: 24357014 DOI: 10.1002/stem.1622] [Cited by in Crossref: 82] [Cited by in F6Publishing: 63] [Article Influence: 13.7] [Reference Citation Analysis]
491 Ting S, Lecina M, Chan YC, Tse HF, Reuveny S, Oh SK. Nutrient supplemented serum-free medium increases cardiomyogenesis efficiency of human pluripotent stem cells. World J Stem Cells 2013;5:86-97. [PMID: 23904910 DOI: 10.4252/wjsc.v5.i3.86] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
492 Blazeski A, Zhu R, Hunter DW, Weinberg SH, Zambidis ET, Tung L. Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractility. Prog Biophys Mol Biol. 2012;110:166-177. [PMID: 22971665 DOI: 10.1016/j.pbiomolbio.2012.07.013] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
493 Abu-Bonsrah KD, Zhang D, Bjorksten AR, Dottori M, Newgreen DF. Generation of Adrenal Chromaffin-like Cells from Human Pluripotent Stem Cells. Stem Cell Reports 2018;10:134-50. [PMID: 29233551 DOI: 10.1016/j.stemcr.2017.11.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
494 Sepac A, Si-Tayeb K, Sedlic F, Barrett S, Canfield S, Duncan SA, Bosnjak ZJ, Lough JW. Comparison of cardiomyogenic potential among human ESC and iPSC lines. Cell Transplant 2012;21:2523-30. [PMID: 22863088 DOI: 10.3727/096368912X653165] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
495 Flamant S, Chomel JC, Desterke C, Féraud O, Gobbo E, Mitjavila-Garcia MT, Foudi A, Griscelli F, Turhan AG, Bennaceur-Griscelli A. Global MicroRNA Profiling Uncovers miR-206 as a Negative Regulator of Hematopoietic Commitment in Human Pluripotent Stem Cells. Int J Mol Sci 2019;20:E1737. [PMID: 30965622 DOI: 10.3390/ijms20071737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
496 Kajiwara M, Aoi T, Okita K, Takahashi R, Inoue H, Takayama N, Endo H, Eto K, Toguchida J, Uemoto S, Yamanaka S. Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc Natl Acad Sci USA. 2012;109:12538-12543. [PMID: 22802639 DOI: 10.1073/pnas.1209979109] [Cited by in Crossref: 211] [Cited by in F6Publishing: 182] [Article Influence: 23.4] [Reference Citation Analysis]
497 Lewandowski J, Kolanowski TJ, Kurpisz M. Techniques for the induction of human pluripotent stem cell differentiation towards cardiomyocytes. J Tissue Eng Regen Med 2017;11:1658-74. [PMID: 26777594 DOI: 10.1002/term.2117] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
498 Nazareth EJ, Ostblom JE, Lücker PB, Shukla S, Alvarez MM, Oh SK, Yin T, Zandstra PW. High-throughput fingerprinting of human pluripotent stem cell fate responses and lineage bias. Nat Methods 2013;10:1225-31. [PMID: 24141495 DOI: 10.1038/nmeth.2684] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 6.8] [Reference Citation Analysis]
499 Wu J, Platero Luengo A, Gil M, Suzuki K, Cuello C, Morales Valencia M, Parrilla I, Martinez C, Nohalez A, Roca J, Martinez E, Izpisua Belmonte J. Generation of human organs in pigs via interspecies blastocyst complementation. Reprod Dom Anim 2016;51:18-24. [DOI: 10.1111/rda.12796] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
500 de Peppo GM, Marcos-Campos I, Kahler DJ, Alsalman D, Shang L, Vunjak-Novakovic G, Marolt D. Engineering bone tissue substitutes from human induced pluripotent stem cells. Proc Natl Acad Sci USA. 2013;110:8680-8685. [PMID: 23653480 DOI: 10.1073/pnas.1301190110] [Cited by in Crossref: 157] [Cited by in F6Publishing: 126] [Article Influence: 19.6] [Reference Citation Analysis]
501 Jaramillo M, Banerjee I. Endothelial cell co-culture mediates maturation of human embryonic stem cell to pancreatic insulin producing cells in a directed differentiation approach. J Vis Exp. 2012;3759. [PMID: 22491132 DOI: 10.3791/3759] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
502 Li J, Narayanan C, Bian J, Sambo D, Brickler T, Zhang W, Chetty S. A transient DMSO treatment increases the differentiation potential of human pluripotent stem cells through the Rb family. PLoS One 2018;13:e0208110. [PMID: 30540809 DOI: 10.1371/journal.pone.0208110] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
503 Fujita J, Tohyama S, Kishino Y, Okada M, Morita Y. Concise Review: Genetic and Epigenetic Regulation of Cardiac Differentiation from Human Pluripotent Stem Cells. Stem Cells 2019;37:992-1002. [PMID: 31021504 DOI: 10.1002/stem.3027] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 10.5] [Reference Citation Analysis]
504 Wetsel RA, Wang D, Calame DG. Therapeutic potential of lung epithelial progenitor cells derived from embryonic and induced pluripotent stem cells. Annu Rev Med 2011;62:95-105. [PMID: 21226612 DOI: 10.1146/annurev-med-052009-172110] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
505 Karumbayaram S, Novitch BG, Patterson M, Umbach JA, Richter L, Lindgren A, Conway AE, Clark AT, Goldman SA, Plath K. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells. 2009;27:806-811. [PMID: 19350680 DOI: 10.1002/stem.31] [Cited by in Crossref: 269] [Cited by in F6Publishing: 236] [Article Influence: 22.4] [Reference Citation Analysis]
506 Nostro MC, Keller G. Generation of beta cells from human pluripotent stem cells: Potential for regenerative medicine. Semin Cell Dev Biol. 2012;23:701-710. [PMID: 22750147 DOI: 10.1016/j.semcdb.2012.06.010] [Cited by in Crossref: 71] [Cited by in F6Publishing: 61] [Article Influence: 7.9] [Reference Citation Analysis]
507 Kadari A, Mekala S, Wagner N, Malan D, Köth J, Doll K, Stappert L, Eckert D, Peitz M, Matthes J, Sasse P, Herzig S, Brüstle O, Ergün S, Edenhofer F. Robust Generation of Cardiomyocytes from Human iPS Cells Requires Precise Modulation of BMP and WNT Signaling. Stem Cell Rev Rep 2015;11:560-9. [PMID: 25392050 DOI: 10.1007/s12015-014-9564-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
508 Hayashi Y, Saitou M, Yamanaka S. Germline development from human pluripotent stem cells toward disease modeling of infertility. Fertility and Sterility 2012;97:1250-9. [DOI: 10.1016/j.fertnstert.2012.04.037] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
509 Takayama N, Nishimura S, Nakamura S, Shimizu T, Ohnishi R, Endo H, Yamaguchi T, Otsu M, Nishimura K, Nakanishi M, Sawaguchi A, Nagai R, Takahashi K, Yamanaka S, Nakauchi H, Eto K. Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med. 2010;207:2817-2830. [PMID: 21098095 DOI: 10.1084/jem.20100844] [Cited by in Crossref: 233] [Cited by in F6Publishing: 186] [Article Influence: 21.2] [Reference Citation Analysis]
510 Abdelalim EM, Emara MM. Advances and challenges in the differentiation of pluripotent stem cells into pancreatic β cells. World J Stem Cells 2015;7:174-81. [PMID: 25621117 DOI: 10.4252/wjsc.v7.i1.174] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
511 Hoshina A, Kawamoto T, Sueta SI, Mae SI, Araoka T, Tanaka H, Sato Y, Yamagishi Y, Osafune K. Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers. Sci Rep 2018;8:6375. [PMID: 29686294 DOI: 10.1038/s41598-018-24714-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
512 Ha HY, Jang SH, Jung JW. The use of pluripotent stem cell for personalized cell therapies against neurological disorders. J Biomed Biotechnol 2011;2011:520816. [PMID: 22203784 DOI: 10.1155/2011/520816] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
513 Chen S, Borowiak M, Fox JL, Maehr R, Osafune K, Davidow L, Lam K, Peng LF, Schreiber SL, Rubin LL, Melton D. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat Chem Biol. 2009;5:258-265. [PMID: 19287398 DOI: 10.1038/nchembio.154] [Cited by in Crossref: 370] [Cited by in F6Publishing: 316] [Article Influence: 30.8] [Reference Citation Analysis]
514 Colman A, Dreesen O. Pluripotent Stem Cells and Disease Modeling. Cell Stem Cell 2009;5:244-7. [DOI: 10.1016/j.stem.2009.08.010] [Cited by in Crossref: 78] [Cited by in F6Publishing: 62] [Article Influence: 6.5] [Reference Citation Analysis]
515 Woolnough JL, Atwood BL, Liu Z, Zhao R, Giles KE. The Regulation of rRNA Gene Transcription during Directed Differentiation of Human Embryonic Stem Cells. PLoS One 2016;11:e0157276. [PMID: 27299313 DOI: 10.1371/journal.pone.0157276] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
516 Sequiera GL, Mehta A, Ooi TH, Shim W. Ontogenic development of cardiomyocytes derived from transgene-free human induced pluripotent stem cells and its homology with human heart. Life Sciences 2013;92:63-71. [DOI: 10.1016/j.lfs.2012.10.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
517 Rezania A, Bruin JE, Riedel MJ, Mojibian M, Asadi A, Xu J, Gauvin R, Narayan K, Karanu F, O’Neil JJ. Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes. 2012;61:2016-2029. [PMID: 22740171 DOI: 10.2337/db11-1711] [Cited by in Crossref: 356] [Cited by in F6Publishing: 287] [Article Influence: 39.6] [Reference Citation Analysis]
518 Huang HN, Chen SY, Hwang SM, Yu CC, Su MW, Mai W, Wang HW, Cheng WC, Schuyler SC, Ma N, Lu FL, Lu J. miR-200c and GATA binding protein 4 regulate human embryonic stem cell renewal and differentiation. Stem Cell Res 2014;12:338-53. [PMID: 24365599 DOI: 10.1016/j.scr.2013.11.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
519 Minami I, Yamada K, Otsuji TG, Yamamoto T, Shen Y, Otsuka S, Kadota S, Morone N, Barve M, Asai Y, Tenkova-Heuser T, Heuser JE, Uesugi M, Aiba K, Nakatsuji N. A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions. Cell Rep. 2012;2:1448-1460. [PMID: 23103164 DOI: 10.1016/j.celrep.2012.09.015] [Cited by in Crossref: 182] [Cited by in F6Publishing: 145] [Article Influence: 20.2] [Reference Citation Analysis]
520 Bilic J, Belmonte JCI. Concise Review: Induced Pluripotent Stem Cells Versus Embryonic Stem Cells: Close Enough or Yet Too Far Apart? STEM CELLS 2012;30:33-41. [DOI: 10.1002/stem.700] [Cited by in Crossref: 151] [Cited by in F6Publishing: 125] [Article Influence: 15.1] [Reference Citation Analysis]
521 Wang Y, Umeda K, Nakayama N. Collaboration between WNT and BMP signaling promotes hemoangiogenic cell development from human fibroblast-derived iPS cells. Stem Cell Research 2010;4:223-31. [DOI: 10.1016/j.scr.2010.03.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
522 Geens M, Mateizel I, Sermon K, De Rycke M, Spits C, Cauffman G, Devroey P, Tournaye H, Liebaers I, Van de Velde H. Human embryonic stem cell lines derived from single blastomeres of two 4-cell stage embryos. Hum Reprod 2009;24:2709-17. [PMID: 19633307 DOI: 10.1093/humrep/dep262] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
523 Isono W, Kawasaki T, Ichida JK, Ayabe T, Hiraike O, Umezawa A, Akutsu H. The combination of dibenzazepine and a DOT1L inhibitor enables a stable maintenance of human naïve-state pluripotency in non-hypoxic conditions. Regen Ther 2020;15:161-8. [PMID: 33426214 DOI: 10.1016/j.reth.2020.08.001] [Reference Citation Analysis]
524 Gokoh M, Nishio M, Nakamura N, Matsuyama S, Nakahara M, Suzuki S, Mitsumoto M, Akutsu H, Umezawa A, Yasuda K. Early senescence is not an inevitable fate of human-induced pluripotent stem-derived cells. Cell Reprogram. 2011;13:361-370. [PMID: 21718107 DOI: 10.1089/cell.2011.0004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
525 Fujimori K, Matsumoto T, Kisa F, Hattori N, Okano H, Akamatsu W. Escape from Pluripotency via Inhibition of TGF-β/BMP and Activation of Wnt Signaling Accelerates Differentiation and Aging in hPSC Progeny Cells. Stem Cell Reports 2017;9:1675-91. [PMID: 29107593 DOI: 10.1016/j.stemcr.2017.09.024] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 10.3] [Reference Citation Analysis]
526 Kumar M, Kaushalya SK, Gressens P, Maiti S, Mani S. Optimized Derivation and Functional Characterization of 5-HT Neurons from Human Embryonic Stem Cells. Stem Cells and Development 2009;18:615-28. [DOI: 10.1089/scd.2008.0181] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
527 Unternaehrer JJ, Daley GQ. Induced pluripotent stem cells for modelling human diseases. Philos Trans R Soc Lond B Biol Sci 2011;366:2274-85. [PMID: 21727133 DOI: 10.1098/rstb.2011.0017] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 6.2] [Reference Citation Analysis]
528 Hoffmann A, Sportelli V, Ziller M, Spengler D. From the Psychiatrist's Couch to Induced Pluripotent Stem Cells: Bipolar Disease in a Dish. Int J Mol Sci 2018;19:E770. [PMID: 29517996 DOI: 10.3390/ijms19030770] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
529 Tsutsui H, Valamehr B, Hindoyan A, Qiao R, Ding X, Guo S, Witte ON, Liu X, Ho CM, Wu H. An optimized small molecule inhibitor cocktail supports long-term maintenance of human embryonic stem cells. Nat Commun. 2011;2:167. [PMID: 21266967 DOI: 10.1038/ncomms1165] [Cited by in Crossref: 125] [Cited by in F6Publishing: 107] [Article Influence: 12.5] [Reference Citation Analysis]
530 Freund C, Mummery CL. Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models. J Cell Biochem 2009;107:592-9. [PMID: 19449339 DOI: 10.1002/jcb.22164] [Cited by in Crossref: 66] [Cited by in F6Publishing: 50] [Article Influence: 5.5] [Reference Citation Analysis]
531 Andersson TB, Ingelman-sundberg M. Livers cells derived from human embryonic stem cells. Drug Discovery Today: Technologies 2008;5:e143-7. [DOI: 10.1016/j.ddtec.2008.09.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
532 Mae SI, Shono A, Shiota F, Yasuno T, Kajiwara M, Gotoda-Nishimura N, Arai S, Sato-Otubo A, Toyoda T, Takahashi K, Nakayama N, Cowan CA, Aoi T, Ogawa S, McMahon AP, Yamanaka S, Osafune K. Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotent stem cells. Nat Commun. 2013;4:1367. [PMID: 23340407 DOI: 10.1038/ncomms2378] [Cited by in Crossref: 210] [Cited by in F6Publishing: 161] [Article Influence: 26.3] [Reference Citation Analysis]